- en: '7'
  id: totrans-0
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: '7  '
- en: Moderna and OpenAI – Biotech and AGI Breakthroughs
  id: totrans-1
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 'Moderna和OpenAI——生物技术和人工智能的突破  '
- en: '[*Chapter 6*](B21008_06.xhtml#_idTextAnchor179) offered a deep dive into the
    unfortunate collapse of **Silicon Valley Bank** (**SVB**), with the narrative
    compared to a renowned pastry chef’s ambitious yet flawed endeavor of baking a
    record-breaking cake. It emphasized the importance of balance, accurate measurement,
    and understanding how elements interact, and how a better understanding of market
    sentiment using AI and ChatGPT might have offered a different insight into the
    impending collapse.'
  id: totrans-2
  prefs: []
  type: TYPE_NORMAL
  zh: '[*第六章*](B21008_06.xhtml#_idTextAnchor179)深入探讨了**硅谷银行**（**SVB**）的悲惨崩溃，并将这一事件与一位著名糕点师雄心勃勃但失败的尝试——烤制一款破纪录蛋糕的经历作比较。它强调了平衡、精确测量和理解各个因素之间的相互作用的重要性，以及通过AI和ChatGPT更好地理解市场情感，可能为即将到来的崩溃提供了不同的见解。'
- en: 'That chapter also introduced the Sentinel Strategy, an innovative trading strategy
    that uses social media sentiment analysis and NLP with the Twitter (now X) API.
    In parallel, it highlighted the Financial Fortress Strategy, combining traditional
    financial metrics with social media sentiment to create a powerful trading scheme.
    [*Chapter 6*](B21008_06.xhtml#_idTextAnchor179) also presented BankRegulatorGPT,
    an AI model designed for financial regulation tasks. It provided an in-depth guide
    on setting up the AI agent and discussed its applications in the finance field.
    In doing so, we delved into the Regional Bank ETF: The Commercial Real Estate
    Strategy, utilizing AI tools and Python code examples to outline a creative commercial
    real estate trade. Power BI visualization techniques were explored in detail –
    first for visualizing the trading strategies and then for creating a visualization
    of the commercial real estate trading strategy. Lastly, we concluded with an analysis
    of AI regulation, emphasizing its importance in mitigating risks associated with
    AI use in the financial sector. It underlined the need for proper rules and supervision
    to ensure the responsible application of AI in finance.'
  id: totrans-3
  prefs: []
  type: TYPE_NORMAL
  zh: '本章还介绍了哨兵策略（Sentinel Strategy），这是一种创新的交易策略，利用社交媒体情感分析和自然语言处理（NLP）与Twitter（现为X）API相结合。同时，还强调了金融堡垒策略（Financial
    Fortress Strategy），该策略将传统的财务指标与社交媒体情感结合，创建了一个强大的交易方案。[*第六章*](B21008_06.xhtml#_idTextAnchor179)还展示了BankRegulatorGPT，这是一个为金融监管任务设计的AI模型。它提供了关于如何设置AI代理的深入指南，并讨论了其在金融领域的应用。在此过程中，我们深入探讨了区域银行ETF：商业房地产策略，利用AI工具和Python代码示例，概述了一个创意的商业房地产交易。Power
    BI可视化技术被详细探讨——首先是可视化交易策略，其次是创建商业房地产交易策略的可视化。最后，我们总结了AI监管的分析，强调了其在减轻AI在金融领域使用中可能带来的风险方面的重要性。它强调了制定适当规则和监督的必要性，以确保AI在金融领域的负责任应用。  '
- en: In this chapter, prepare to embark on a thrilling exploration where biotechnology
    meets the innovative domain of **artificial intelligence** (**AI**), finance,
    and data visualization in the form of AI and ChatGPT. We will journey into the
    heart of Moderna, a name that is synonymous with innovation and ambition that’s
    not only etched in the annals of medical history for its groundbreaking COVID-19
    vaccine but that also represents the epitome of technological synergy.
  id: totrans-4
  prefs: []
  type: TYPE_NORMAL
  zh: '在本章中，准备迎接一次激动人心的探索之旅，生物技术与创新领域的**人工智能**（**AI**）、金融和数据可视化相结合，以AI和ChatGPT的形式展现。我们将深入Moderna的核心，Moderna这一名字不仅因其开创性的COVID-19疫苗而铭刻在医学历史的篇章中，更代表了技术协同的巅峰。  '
- en: From deploying AI to accelerating drug discovery to leveraging quantum computing
    in partnership with giants such as IBM and Carnegie Mellon, Moderna’s vision transcends
    conventional boundaries. Here, we’ll unveil how Moderna orchestrates a perfect
    symphony of science, technology, and business acumen. You’ll discover a novel
    investment strategy called Moderna Momentum, a sentiment-sensitive masterpiece
    that uses AI and ChatGPT and is visualized through Power BI. You’ll meet the future
    of drug development with AI personas such as FoodandDrugAdminGPT and witness how
    Moderna is shaping the future of cancer care, pandemic response, and much more.
  id: totrans-5
  prefs: []
  type: TYPE_NORMAL
  zh: '从部署AI到加速药物发现，再到与IBM和卡内基梅隆等巨头合作，利用量子计算，Moderna的愿景超越了传统的界限。在这里，我们将揭示Moderna如何将科学、技术和商业智慧完美融合。你将发现一种名为Moderna
    Momentum的投资策略，这是一种情感敏感的杰作，利用AI和ChatGPT，通过Power BI进行可视化。你将遇到药物开发的未来AI人物，如FoodandDrugAdminGPT，并见证Moderna如何塑造癌症治疗、疫情响应等领域的未来。  '
- en: Get ready to be inspired, enlightened, and enthralled by a narrative that weaves
    together the brilliance of Moderna’s strategy, the potential of AI and ChatGPT,
    the precision of financial analysis, and the beauty of Power BI visualizations.
    This chapter is not just a read – it’s an experience, a vision of the future where
    science, technology, and humanity converge to create a brighter, healthier, and
    more prosperous world for all. Welcome to the frontier of innovation!
  id: totrans-6
  prefs: []
  type: TYPE_NORMAL
  zh: 准备好被启发、开阔视野并深深吸引吧！本章将带你领略Moderna战略的光辉、AI和ChatGPT的潜力、金融分析的精准性以及Power BI可视化的美感。这不仅仅是一篇阅读材料——它是一次体验，一种未来的愿景，在这个愿景中，科学、技术和人类共同汇聚，创造出一个更加光明、健康和繁荣的世界。欢迎来到创新的前沿！
- en: 'In this chapter, we will cover the following topics:'
  id: totrans-7
  prefs: []
  type: TYPE_NORMAL
  zh: 本章将涵盖以下主题：
- en: 'Navigating the Biotech frontier with Moderna: Uncover how Moderna’s journey
    with groundbreaking **messenger RNA** (**mRNA**) technology is akin to crafting
    a blockbuster movie, with detailed planning, execution, and market acceptance
    playing crucial roles.'
  id: totrans-8
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 与Moderna一同探索生物技术前沿：揭示Moderna在突破性的**信使RNA**（**mRNA**）技术上的发展历程，如何像打造一部大片一样，通过详细的规划、执行和市场接受度，扮演着至关重要的角色。
- en: 'Quantum horizons and AI mastery with IBM and Carnegie Mellon: Explore Moderna’s
    revolutionary partnerships in quantum computing and AI, forging a path to next-gen
    drug discovery, and building an AI-driven symphony in medicine.'
  id: totrans-9
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 与IBM和卡内基梅隆大学共同探索量子视野与AI掌控：探讨Moderna在量子计算和AI方面的革命性合作，开辟通向下一代药物发现的道路，并构建医学中的AI驱动交响乐。
- en: 'Revolutionizing cancer care and confronting future pandemics: Explore Moderna’s
    ambitious plans in oncology, personalized therapies, and multi-valent vaccines,
    redefining the landscape of medicine for generations to come.'
  id: totrans-10
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 革新癌症护理并应对未来大流行：探讨Moderna在肿瘤学、个性化治疗和多价疫苗方面的雄心计划，重新定义未来几代人医学的格局。
- en: 'Outsourcing and global expansion strategy: Understand Moderna’s strategic move
    toward outsourcing pharma manufacturing for innovation, agility, and global reach,
    with a focus on quality assurance and ethical considerations.'
  id: totrans-11
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 外包与全球扩张战略：了解Moderna如何通过外包制药制造，推动创新、提高灵活性和拓展全球市场，同时注重质量保证和伦理考量。
- en: Discover Moderna Momentum a novel, sentiment-sensitive investment strategy that
    embodies the intricate nature of biotech investing, visualized through Power BI.
  id: totrans-12
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 发现Moderna Momentum——一种新颖的、情感敏感的投资策略，体现了生物技术投资的复杂性，并通过Power BI呈现其可视化效果。
- en: 'Unleashing collaborative intelligence with Jarvis, HuggingGPT, and FoodandDrugAdminGPT:
    Dive into the integration of these innovative AI models in the pharmaceutical
    landscape. From strategic task planning with FoodandDrugAdminGPT to crafting seamless
    GUIs with Gradio, you will explore how they synergize to offer intelligent plans,
    employ expert models, and navigate complex multimodal AI challenges, all while
    accelerating drug development and approval processes.'
  id: totrans-13
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 与Jarvis、HuggingGPT和FoodandDrugAdminGPT共同释放协作智能：深入探索这些创新AI模型在制药领域的融合应用。从通过FoodandDrugAdminGPT进行战略任务规划，到利用Gradio构建无缝的GUI，你将探索它们如何协同作用，提供智能规划、应用专家模型并应对复杂的多模态AI挑战，同时加速药物开发和审批流程。
- en: 'Revolutionizing biotech with GPT-4 and OpenAI’s pinnacle against tech giants:
    Witness how GPT-4 is reshaping drug discovery at Moderna, and learn how OpenAI’s
    triumph over colossal tech giants displays AI’s transformative power.'
  id: totrans-14
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 利用GPT-4和OpenAI在科技巨头面前的巅峰之作，革新生物技术：见证GPT-4如何在Moderna重新塑造药物发现，并了解OpenAI如何在挑战科技巨头时展示AI的变革力量。
- en: 'Artificial general intelligence’s (AGI’s) future in finance and alignment with
    human values: Envision a world where AGI becomes a core pillar of the financial
    ecosystem, exploring thrilling territories such as AGI-driven business intelligence,
    financial market predictions, and real-time risk management.'
  id: totrans-15
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 人工通用智能（AGI）在金融领域的未来以及与人类价值观的对齐：设想一个AGI成为金融生态系统核心支柱的世界，探索令人激动的领域，如AGI驱动的商业智能、金融市场预测和实时风险管理。
- en: As we examine into the intricacies of Moderna’s journey to develop a COVID-19
    vaccine, we invite you to consider an unconventional comparison. We aim to draw
    parallels between the development of a groundbreaking drug using mRNA technology
    and the creation of a successful, big-budget blockbuster movie. This analogy is
    designed to distill the complex factors leading to a blockbuster product’s success
    into a relatable narrative, illustrating how detailed planning, meticulous execution,
    and market acceptance play crucial roles in both pharmaceuticals and film.
  id: totrans-16
  prefs: []
  type: TYPE_NORMAL
  zh: 在我们深入研究莫德纳研发新冠疫苗的复杂过程时，我们邀请你考虑一个非传统的对比。我们旨在将使用mRNA技术研发突破性药物的过程与成功的大制作电影的创作进行对比。这个类比旨在将导致一款大片成功的复杂因素提炼为一个易于理解的叙事，展示精心的规划、细致的执行和市场接受度在制药和电影制作中所起的关键作用。
- en: The blockbuster saga – understanding the success of Moderna’s COVID-19 vaccine
  id: totrans-17
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 这部大片传奇——理解莫德纳新冠疫苗的成功
- en: 'In this section, we will draw parallels between Moderna’s groundbreaking work
    in biotechnology and the blockbuster success of James Cameron’s *Avatar: The Way
    of Water*. We aim to simplify the complex world of biotech by likening it to the
    more familiar realm of filmmaking. By doing so, we will illuminate key principles
    of innovation, risk, and market dynamics that are crucial for making informed
    decisions in finance.'
  id: totrans-18
  prefs: []
  type: TYPE_NORMAL
  zh: 在本节中，我们将对比莫德纳在生物技术领域的开创性工作与詹姆斯·卡梅隆的*《阿凡达：水之道》*的巨大的成功。我们的目标是通过将复杂的生物技术领域比作更为熟悉的电影制作领域，来简化这一复杂世界。通过这种方式，我们将阐明创新、风险和市场动态等关键原则，这些原则对于在金融领域做出明智决策至关重要。
- en: 'Imagine an innovative biotechnology company, Moderna, at the helm of a daring
    venture: creating an effective and high-efficacy vaccine, harnessing the power
    of mRNA technology to combat the worldwide COVID-19 pandemic. This was to be Moderna’s
    most significant breakthrough, an accomplishment that would change the course
    of global health.'
  id: totrans-19
  prefs: []
  type: TYPE_NORMAL
  zh: 想象一下，一家创新的生物技术公司，莫德纳，正在领导一项大胆的事业：研发一种有效且高效的疫苗，利用mRNA技术抗击全球新冠疫情。这将是莫德纳最重要的突破，一项将改变全球健康格局的成就。
- en: 'Simultaneously, envision a renowned movie studio, led by James Cameron, working
    on the sequel to a movie that redefined the cinematic experience – *Avatar: The
    Way of Water*. The film was set to break all previous records, with the largest
    production budget for a film ever made of $460 million.'
  id: totrans-20
  prefs: []
  type: TYPE_NORMAL
  zh: 与此同时，设想一个著名的电影工作室，由詹姆斯·卡梅隆领导，正在制作一部重新定义电影体验的电影续集——*《阿凡达：水之道》*。该电影有望打破所有既往纪录，成为有史以来制作成本最高的电影，总预算为4.6亿美元。
- en: The production of both the vaccine and the movie were colossal undertakings,
    grabbing the attention of respective industry stakeholders and the world at large.
    Everyone watched anxiously as Moderna underwent clinical trials, as James Cameron
    and his team worked tirelessly behind the scenes, perfecting the script, visual
    effects, and the ensemble cast’s performance.
  id: totrans-21
  prefs: []
  type: TYPE_NORMAL
  zh: 无论是疫苗的生产，还是电影的制作，都是庞大的工程，吸引了各自行业利益相关者及全球的关注。人们焦急地关注着莫德纳进行临床试验的过程，同时詹姆斯·卡梅隆和他的团队也在幕后不懈努力，完善剧本、视觉效果以及演员阵容的表现。
- en: 'In the world of social media, critics and skeptics predicted failure for both
    ventures due to their high risk and unproven technology or narrative. However,
    when the Moderna vaccine received FDA approval and *Avatar: The Way of Water*
    hit the silver screens, the world bore witness to two significant successes.'
  id: totrans-22
  prefs: []
  type: TYPE_NORMAL
  zh: 在社交媒体的世界里，评论家和怀疑者们曾预测两项事业都将因其高风险和未验证的技术或叙事而失败。然而，当莫德纳的疫苗获得FDA批准，*《阿凡达：水之道》*在银幕上映时，世界见证了两项重大的成功。
- en: The vaccine was hailed as a game-changer, with Moderna receiving nearly $2.5
    billion for its COVID-19 vaccine development and production, subsequently earning
    $17.7 billion in 2021, $19.3 billion in 2022, and a projected $5 billion in 2023
    from vaccine revenue. Moderna earned $42 billion in COVID-19 vaccine revenue between
    2021 and 2023, which is nearly 17 times its development and production costs.
  id: totrans-23
  prefs: []
  type: TYPE_NORMAL
  zh: 该疫苗被誉为一项颠覆性的创新，莫德纳因其新冠疫苗的研发和生产获得了近25亿美元的资金，随后在2021年赚取了177亿美元，2022年赚取了193亿美元，并预计2023年从疫苗收入中获得50亿美元。莫德纳在2021年至2023年间从新冠疫苗中赚取了420亿美元的收入，几乎是其研发和生产成本的17倍。
- en: 'Similarly, *Avatar: The Way of Water*, despite having a huge film budget of
    $460 million, recouped its production costs and more. It achieved domestic revenue
    of $684 million and a stunning $1.6 billion internationally, with China being
    the largest market outside of the US, contributing $245 million. In total, the
    movie garnered a breathtaking $2.32 billion in worldwide gross revenue, which
    earned five times its production costs.'
  id: totrans-24
  prefs: []
  type: TYPE_NORMAL
  zh: 同样，*《阿凡达：水之道》*尽管拥有4.6亿美元的巨大电影预算，却收回了制作成本并获得了更多。它在国内收入6.84亿美元，国际票房高达16亿美元，其中中国是美国之外最大的市场，贡献了2.45亿美元。总的来说，这部电影获得了惊人的23.2亿美元全球总票房，是制作成本的五倍。
- en: Both these instances demonstrate the importance of vision, investment, and innovation
    in achieving monumental success. The creation of a blockbuster drug, much like
    the production of a blockbuster movie, requires an intricate balance of creativity
    and meticulous planning. Each venture represents a significant risk, but with
    the right ingredients, careful management, and a dash of good fortune, they can
    result in overwhelming success.
  id: totrans-25
  prefs: []
  type: TYPE_NORMAL
  zh: 这两个例子都展示了远见、投资与创新在取得巨大成功中的重要性。创造一款爆款药物，就像制作一部爆款电影一样，需要在创造力和周密规划之间找到精细的平衡。每个项目都是一次巨大的风险，但如果具备正确的成分、精心的管理，以及一点好运，它们能够带来压倒性的成功。
- en: 'Here are some intriguing parallels between creating a hit movie and a successful
    vaccine:'
  id: totrans-26
  prefs: []
  type: TYPE_NORMAL
  zh: 这里有一些关于制作一部热门电影和成功疫苗之间的有趣相似之处：
- en: '**Research and development (pre-production)**: This is the foundation upon
    which everything else is built. Without an effective drug or a compelling story,
    all other efforts are likely to fail.'
  id: totrans-27
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**研究与开发（前期制作）**：这是所有其他工作的基础。如果没有有效的药物或引人入胜的故事，所有其他努力都可能会失败。'
- en: '**Regulatory approval and censor board clearance**: No matter how promising
    a drug or film might be, if it doesn’t pass these legal hurdles, it won’t be able
    to reach the public.'
  id: totrans-28
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**监管批准与审查委员会批准**：无论药物或电影多么有前景，如果未能通过这些法律障碍，它们将无法进入公众市场。'
- en: '**Clinical trials and test screenings**: The feedback from these steps can
    make or break a product. A drug that shows severe side effects in clinical trials
    won’t make it to market, and a movie that tests poorly might need substantial
    edits or risk box-office failure.'
  id: totrans-29
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**临床试验与测试放映**：这些步骤的反馈可能决定一个产品的成败。在临床试验中显示严重副作用的药物无法上市，而在测试放映中表现不佳的电影可能需要大幅修改，否者将面临票房失败的风险。'
- en: '**Marketing and promotion**: A high-quality drug or film won’t succeed if people
    aren’t aware of it. Marketing and promotion are key to driving awareness and interest.'
  id: totrans-30
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**营销与推广**：即使是一部高质量的药物或电影，如果人们不了解它，也不会成功。营销与推广是驱动认知与兴趣的关键。'
- en: '**Distribution**: The best product in the world won’t succeed if it doesn’t
    reach its intended audience. Effective distribution strategies are key to ensuring
    that a drug is available in pharmacies, or a movie is screened in theaters or
    available on streaming platforms.'
  id: totrans-31
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**分发**：即使是世界上最好的产品，如果无法到达其目标受众，也不会成功。有效的分发策略是确保药物能进入药房，或者电影能够在影院上映或在流媒体平台上播放的关键。'
- en: '**Reception and feedback**: The market’s reaction will ultimately decide the
    fate of a drug or a film. Success hinges on how well the product is received and
    accepted by its intended audience, be it patients/doctors or movie-goers.'
  id: totrans-32
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**反响与反馈**：市场的反应最终将决定药物或电影的命运。成功取决于产品是否被目标受众接受，无论是患者/医生还是观影人群。'
- en: '**Sequels and next-generation treatments**: While not immediately crucial to
    the success of the initial product, the potential for sequels or next-generation
    treatments can greatly extend the lifespan and profitability of a successful drug
    or film.'
  id: totrans-33
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**续集与下一代治疗**：虽然对于初期产品的成功并非立刻至关重要，但续集或下一代治疗的潜力可以大大延长成功药物或电影的生命周期及盈利能力。'
- en: The next section delves into Moderna’s journey, illuminating its unique methodologies,
    strategic collaborations, and ambitious goals as it continues to pioneer a new
    paradigm in medicine.
  id: totrans-34
  prefs: []
  type: TYPE_NORMAL
  zh: 下一部分深入探讨了莫德纳的旅程，阐明了其独特的方法论、战略合作以及雄心勃勃的目标，展示了其在医学领域开创新范式的持续努力。
- en: Moderna’s mRNA odyssey and the transformation of biomedicine
  id: totrans-35
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 莫德纳的mRNA历程与生物医学的变革
- en: Moderna, founded in 2010 and headquartered in Cambridge, Massachusetts, has
    emerged as a leading force in biotechnology with its innovative focus on mRNA-based
    therapies. Leveraging synthetic mRNA, Moderna instructs patients’ cells to produce
    proteins, laying the groundwork for therapies to prevent, treat, or cure diseases.
    The rapid validation of Moderna’s mRNA technology with its COVID-19 vaccine, authorized
    in December 2020, has brought global attention to this revolutionary approach.
  id: totrans-36
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna成立于2010年，总部位于马萨诸塞州剑桥市，凭借其在mRNA基础疗法上的创新性聚焦，已经成为生物技术领域的领先力量。通过利用合成mRNA，Moderna指示患者的细胞合成蛋白，为预防、治疗或治愈疾病的疗法奠定了基础。Moderna的mRNA技术通过其COVID-19疫苗（于2020年12月获得授权）获得了快速验证，全球对这一革命性方法的关注也随之增加。
- en: We want to use focused subsections to break down complex topics into digestible
    pieces, covering everything from Moderna’s pivotal role in the COVID-19 pandemic
    to its broader applications and innovative strategies. This matters to you because
    understanding Moderna’s approach can offer valuable insights into investment opportunities,
    risk assessment, and financial reporting in the rapidly evolving biotech sector.
  id: totrans-37
  prefs: []
  type: TYPE_NORMAL
  zh: 我们希望通过聚焦子章节，将复杂的主题分解成易于消化的部分，内容涵盖从Moderna在COVID-19大流行中的关键角色，到其更广泛的应用和创新策略。这对你很重要，因为理解Moderna的方法可以为投资机会、风险评估和快速发展的生物技术领域的财务报告提供宝贵的见解。
- en: The impact of mRNA-1273 – battling a pandemic
  id: totrans-38
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: mRNA-1273的影响——抗击大流行
- en: Moderna’s mRNA-1273, the company’s COVID-19 vaccine, has proven highly effective,
    becoming a vital tool in combating the global pandemic. As of early 2022, Moderna
    boasts 44 mRNA development programs, with 25 in clinical trials, spanning therapeutic
    areas such as infectious disease, oncology, cardiovascular disease, and rare genetic
    diseases.
  id: totrans-39
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna的mRNA-1273，即该公司的COVID-19疫苗，已被证明具有高度的有效性，成为应对全球大流行的关键工具。截至2022年初，Moderna拥有44个mRNA开发项目，其中25个处于临床试验阶段，涵盖了感染性疾病、肿瘤学、心血管疾病和罕见遗传疾病等治疗领域。
- en: Harnessing the power of mRNA – a new medicinal frontier
  id: totrans-40
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 驾驭mRNA的力量——一个新的医学前沿
- en: 'In addition to their groundbreaking work on COVID-19, Moderna’s research focuses
    on five therapeutic areas: infectious diseases, immuno-oncology, rare diseases,
    cardiovascular diseases, and autoimmune diseases. The company has developed seven
    distinct modalities or categories of potential mRNA medicines with shared features,
    encompassing applications from infectious disease vaccines to inhaled pulmonary
    therapeutics.'
  id: totrans-41
  prefs: []
  type: TYPE_NORMAL
  zh: 除了在COVID-19领域的开创性工作，Moderna的研究还聚焦于五个治疗领域：传染性疾病、免疫肿瘤学、罕见疾病、心血管疾病和自身免疫性疾病。该公司开发了七种具有共同特征的潜在mRNA药物类别，涵盖了从传染性疾病疫苗到吸入性肺部治疗的多种应用。
- en: Applications across medical domains
  id: totrans-42
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 医学领域的应用
- en: Moderna’s active clinic programs extend to areas such as oncology, where they
    are pioneering mRNA-based personalized cancer vaccines and intratumoral immuno-oncology
    therapies. In cardiovascular disease, efforts are directed toward treating heart
    failure and myocardial infarction. For rare genetic disorders, Moderna is developing
    treatments for conditions such as **methylmalonic** **acidemia** (**MMA**).
  id: totrans-43
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna的活跃临床项目延伸至肿瘤学领域，在这里他们正在开创基于mRNA的个性化癌症疫苗和肿瘤内免疫肿瘤治疗。在心血管疾病方面，他们的努力主要集中在治疗心力衰竭和心肌梗死。对于罕见遗传病，Moderna正在开发针对**甲基丙二酸血症**（**MMA**）等疾病的治疗方法。
- en: Redefining vaccine development
  id: totrans-44
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 重定义疫苗开发
- en: Diverging from traditional, complex vaccine development, Moderna’s methodology
    leverages mRNA to instruct patients’ cells in protein synthesis, activating the
    immune system against illness. This innovative approach has enabled rapid vaccine
    development and the pursuit of previously non-addressable targets.
  id: totrans-45
  prefs: []
  type: TYPE_NORMAL
  zh: 与传统、复杂的疫苗开发方法不同，Moderna的技术利用mRNA指示患者的细胞进行蛋白质合成，从而激活免疫系统对抗疾病。这一创新方法使得疫苗的快速开发成为可能，并推动了此前无法解决的目标的探索。
- en: A new paradigm for pharmaceutical innovation
  id: totrans-46
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 药物创新的新范式
- en: The focus on mRNA and personalized vaccines has differentiated Moderna within
    the pharmaceutical landscape. Their mRNA vaccines, producible through a unified
    “plug-and-play” platform and manufacturable at a single facility, have ushered
    in an era of unprecedented versatility, streamlined research, large-scale production,
    and rapid response to emergent threats. This novel approach to vaccine development
    sets Moderna apart by enhancing speed, flexibility, and efficiency.
  id: totrans-47
  prefs: []
  type: TYPE_NORMAL
  zh: 专注于mRNA和个性化疫苗使Moderna在制药领域中脱颖而出。它们的mRNA疫苗可以通过统一的“即插即用”平台生产，并且能够在单一设施中制造，这开启了前所未有的多功能性时代，简化了研究、大规模生产，并能够迅速应对突发威胁。这种疫苗开发的新方法通过提升速度、灵活性和效率，将Moderna与众不同。
- en: Strategic partnerships and collaborations
  id: totrans-48
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 战略合作伙伴关系与协作
- en: Key to Moderna’s success are strategic collaborations with other organizations
    and companies within the biotech ecosystem. Partnerships with industry giants
    such as AstraZeneca, Merck, Vertex, and CytomX, and government organizations such
    as BARDA and DARPA, have fostered an environment that propels the development
    of mRNA medicines.
  id: totrans-49
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna成功的关键在于与生物技术生态系统内其他组织和公司的战略合作。与行业巨头如阿斯利康、默克、Vertex和CytomX，以及政府组织如BARDA和DARPA的合作，营造了一个推动mRNA药物开发的环境。
- en: Moderna’s journey with mRNA-based therapies represents nothing short of a revolution.
    From its instrumental role in the battle against COVID-19 to its development of
    groundbreaking treatments across various medical domains, Moderna’s innovation
    is reshaping the future of medicine. Its robust pipeline, novel technological
    approach, and strategic partnerships underscore the transformative potential of
    mRNA technology. Truly, Moderna’s odyssey through the realm of mRNA is a resounding
    symphony in the world of biomedicine, infusing hope and offering new pathways
    to healing.
  id: totrans-50
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna的mRNA基础疗法之旅代表着一场革命。从其在抗击COVID-19中的重要作用，到其在多个医学领域开发突破性疗法，Moderna的创新正在重塑医学的未来。其强大的产品管线、创新的技术方法和战略合作伙伴关系凸显了mRNA技术的变革潜力。确实，Moderna在mRNA领域的历程是一场响亮的交响曲，注入了希望并提供了新的治疗路径。
- en: This upcoming section provides a SWOT analysis of Moderna’s strengths, weaknesses,
    opportunities, and threats, offering a comprehensive view of Moderna’s position
    in the industry, its unique capabilities, and the challenges and prospects that
    lie ahead.
  id: totrans-51
  prefs: []
  type: TYPE_NORMAL
  zh: 本节将提供Moderna的SWOT分析，涵盖其优势、劣势、机会和威胁，全面展现Moderna在行业中的定位、独特能力以及面临的挑战和前景。
- en: SWOT analysis of Moderna’s strategic landscape
  id: totrans-52
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: Moderna战略格局的SWOT分析
- en: In this section, we’ll break down Moderna’s strengths, weaknesses, opportunities,
    and threats into focused subsections. Our learning objective is to give you a
    comprehensive view of how Moderna leverages innovative technologies such as mRNA,
    AI, and quantum computing, and what challenges and opportunities these present.
    This is important for you as it offers a multifaceted understanding of Moderna’s
    business model, which you can leverage for investment decisions, risk assessments,
    and strategic financial reporting in the ever-changing landscape of biotechnology
    and AI. Understanding these details is crucial for making well-informed choices
    in a complex industry.
  id: totrans-53
  prefs: []
  type: TYPE_NORMAL
  zh: 在本节中，我们将把Moderna的优势、劣势、机会和威胁拆解为重点小节。我们的学习目标是为你提供一个全面的视角，了解Moderna如何利用mRNA、AI和量子计算等创新技术，以及这些技术带来的挑战和机遇。这对于你来说至关重要，因为它为你提供了多维度的理解，帮助你在不断变化的生物技术和AI领域中做出投资决策、风险评估和战略财务报告。了解这些细节对于在复杂行业中做出明智选择至关重要。
- en: '**These are the strengths** **of Moderna**:'
  id: totrans-54
  prefs: []
  type: TYPE_NORMAL
  zh: '**这些是Moderna的优势** **所在**：'
- en: '**mRNA technology**: The innovative mRNA technology platform allows rapid vaccine
    development'
  id: totrans-55
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**mRNA技术**：创新的mRNA技术平台使得疫苗开发更加迅速'
- en: '**Scale and speed**: Shown by the swift response to COVID-19'
  id: totrans-56
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**规模与速度**：通过对COVID-19的迅速反应展现出来'
- en: '**Strong pipeline**: Robust potential treatments in development across various
    diseases'
  id: totrans-57
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**强大的管线**：在各类疾病中，多个潜在治疗正在开发中'
- en: '**Financial stability**: Boosted by COVID-19 vaccine success'
  id: totrans-58
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**财务稳定性**：受益于COVID-19疫苗的成功'
- en: '**Partnerships with technology leaders**: Collaboration with IBM for quantum
    computing and AI enhances drug discovery, optimizes mRNA medicines, and promotes
    workforce development'
  id: totrans-59
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**与技术领袖的合作**：与IBM在量子计算和AI领域的合作，提升了药物发现，优化了mRNA药物，并促进了劳动力的发展'
- en: '**AI literacy and adoption**: A partnership with **Carnegie Mellon University**
    (**CMU**) to create the AI Academy fostered broad-based AI literacy, upskilling,
    process optimization, and future-proofing the business'
  id: totrans-60
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**AI素养与采纳**：与**卡内基梅隆大学**（**CMU**）合作创建的AI学院，促进了广泛的AI素养提升、技能发展、流程优化，并使公司具备了未来发展的能力。'
- en: '**These are the weaknesses** **of Moderna**:'
  id: totrans-61
  prefs: []
  type: TYPE_NORMAL
  zh: '**这些是Moderna的弱点**：'
- en: '**Reliance on mRNA-1273**: Heavy dependence on the COVID-19 vaccine; needs
    revenue diversification'
  id: totrans-62
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**对mRNA-1273的依赖**：对COVID-19疫苗的高度依赖；需要收入多样化。'
- en: '**Market perception**: Challenges around public perception and trust'
  id: totrans-63
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**市场认知**：关于公众认知和信任的挑战。'
- en: '**Regulatory challenges**: Potential hurdles with new mRNA technology'
  id: totrans-64
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**监管挑战**：新型mRNA技术的潜在障碍。'
- en: '**Complex integration of AI and quantum computing**: As groundbreaking as these
    technologies are, their integration into existing processes could be complex and
    may require significant investment in training, adaptation, and compliance'
  id: totrans-65
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**AI与量子计算的复杂集成**：尽管这些技术具有开创性，它们与现有流程的集成可能会很复杂，并且可能需要在培训、适应和合规性方面进行大量投资。'
- en: '**Potential ethical concerns with AI**: Although addressed in training, the
    ethics of using AI in drug discovery and development could still raise questions
    and concerns that Moderna must be prepared to navigate'
  id: totrans-66
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**AI的潜在伦理问题**：尽管在培训中有所涉及，使用AI进行药物发现和开发的伦理问题仍可能引发问题和担忧，Moderna必须为此做好应对准备。'
- en: 'The following opportunities can be seen as extensions of Moderna’s strengths,
    driving the company’s positioning as a leader in technology-driven breakthroughs
    in biotechnology:'
  id: totrans-67
  prefs: []
  type: TYPE_NORMAL
  zh: 以下机会可以看作是Moderna优势的延伸，推动公司在技术驱动的生物技术突破中定位为领导者：
- en: '**Advanced drug discovery**: Quantum computing and AI could significantly expedite
    and optimize drug discovery'
  id: totrans-68
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**先进的药物发现**：量子计算和AI可能显著加速和优化药物发现过程。'
- en: '**Enhanced understanding and optimization of mRNA medicines**: Predicting molecular
    properties for improved safety and performance'
  id: totrans-69
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**增强对mRNA药物的理解和优化**：预测分子特性，以提高安全性和性能。'
- en: '**Workforce development**: Investment in a quantum-ready workforce and AI literacy
    will make Moderna an early adopter and attractive employer'
  id: totrans-70
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**劳动力发展**：对量子技术准备好的人才和AI素养的投资，将使Moderna成为早期采用者并成为有吸引力的雇主。'
- en: '**Access to cutting-edge technology**: Partnership with IBM for quantum technologies
    provides critical advantages'
  id: totrans-71
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**接触前沿技术**：与IBM在量子技术领域的合作提供了关键优势。'
- en: 'Here are some potential threats or challenges that Moderna should keep in mind:'
  id: totrans-72
  prefs: []
  type: TYPE_NORMAL
  zh: 以下是Moderna应当关注的一些潜在威胁或挑战：
- en: '**Technology dependence**: Heavy reliance on third-party technologies (IBM’s
    quantum computing, AI models, and so on) could make Moderna vulnerable to changes
    in those technologies or partnerships'
  id: totrans-73
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**技术依赖**：对第三方技术（如IBM的量子计算、AI模型等）的高度依赖，可能使Moderna在这些技术或合作伙伴发生变化时变得脆弱。'
- en: '**Ethical scrutiny**: With AI and quantum computing entering uncharted territories
    in drug discovery, Moderna may face ethical scrutiny and regulatory challenges
    specific to these technologies'
  id: totrans-74
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**伦理审查**：随着AI和量子计算进入药物发现的未知领域，Moderna可能面临特定于这些技术的伦理审查和监管挑战。'
- en: In summary, the integration of AI and quantum computing in Moderna’s operations
    provides a multifaceted enhancement to the company’s strengths and opportunities.
    However, it also introduces complexities that must be managed to prevent them
    from becoming weaknesses or threats. The balance between these elements will be
    key to Moderna’s continued success in leveraging these innovative technologies
    for innovation and growth in the biotechnology space.
  id: totrans-75
  prefs: []
  type: TYPE_NORMAL
  zh: 总结来说，AI与量子计算在Moderna运营中的集成，为公司优势和机会提供了多方面的增强。然而，这也带来了必须管理的复杂性，以防它们成为弱点或威胁。这些元素之间的平衡将是Moderna在利用这些创新技术进行生物技术领域创新和增长时持续成功的关键。
- en: This next section provides a glimpse of the technology and medicine that Moderna
    has embraced with the capabilities of AI and quantum computing. This section delves
    into how these technologies are shaping Moderna’s approach to drug discovery,
    clinical trials, post-marketing surveillance, supply chain efficiency, and more.
  id: totrans-76
  prefs: []
  type: TYPE_NORMAL
  zh: 本节内容展示了Moderna如何借助AI和量子计算的能力，拥抱技术和医学。该部分深入探讨了这些技术如何塑造Moderna在药物发现、临床试验、上市后监测、供应链效率等方面的方法。
- en: The integration of AI and quantum computing in Moderna’s therapeutic landscape
  id: totrans-77
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: AI与量子计算在Moderna治疗领域的集成。
- en: In this section, we’ll delve into the transformative role of AI and quantum
    computing in Moderna’s therapeutic landscape. You’ll learn how these cutting-edge
    technologies impact everything from drug discovery and clinical trials to supply
    chain management.
  id: totrans-78
  prefs: []
  type: TYPE_NORMAL
  zh: 在本节中，我们将深入探讨AI和量子计算在莫德纳治疗领域中的变革性作用。你将了解这些尖端技术如何影响从药物发现和临床试验到供应链管理的方方面面。
- en: The learning objective is to equip you with an in-depth understanding of how
    Moderna integrates technology into its operations. This knowledge is crucial for
    anyone interested in investment and trading opportunities within the rapidly evolving
    fields of biotechnology and AI.
  id: totrans-79
  prefs: []
  type: TYPE_NORMAL
  zh: 本节的学习目标是让你深入了解莫德纳如何将技术融入其运营中。这一知识对于任何有意在快速发展的生物技术和AI领域中寻找投资与交易机会的人来说至关重要。
- en: In the next subsection, we’ll focus on the critical role of AI in Moderna’s
    drug discovery process. We’ll explore how AI technologies such as predictive modeling
    and algorithmic analysis are leveraged to identify potential mRNA targets, optimize
    molecular structures, and even predict interactions in combination therapies.
  id: totrans-80
  prefs: []
  type: TYPE_NORMAL
  zh: 在下一小节中，我们将重点关注人工智能在莫德纳药物发现过程中的关键作用。我们将探讨如何利用预测建模和算法分析等AI技术来识别潜在的mRNA靶点、优化分子结构，甚至预测联合疗法中的相互作用。
- en: AI in Moderna’s drug discovery process
  id: totrans-81
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: AI在莫德纳药物发现过程中的应用
- en: 'As you dive into this subsection, keep in mind that identifying the right mRNA
    sequences is the cornerstone of effective drug development. Here, we’ll uncover
    how Moderna utilizes AI to revolutionize this crucial first step:'
  id: totrans-82
  prefs: []
  type: TYPE_NORMAL
  zh: 在深入本小节时，请记住，识别正确的mRNA序列是有效药物开发的基石。在这里，我们将揭示莫德纳如何利用AI来革新这一关键的第一步：
- en: '**Harnessing AI for mRNA** **target identification**'
  id: totrans-83
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**利用AI进行mRNA** **靶点识别**'
- en: '**Example**: AI algorithms can analyze genomic data to identify specific RNA
    sequences that are potential drug targets for various diseases. For Moderna, this
    process could be used to discover novel mRNA-based therapies for conditions such
    as cancer, auto-immune diseases, or viral infections.'
  id: totrans-84
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：AI算法可以分析基因组数据，以识别可能成为各种疾病药物靶点的特定RNA序列。对于莫德纳而言，这一过程可以用于发现用于癌症、自身免疫疾病或病毒感染等疾病的全新mRNA基础疗法。'
- en: '**Using AI to optimize mRNA structure and** **lipid nanoparticles**'
  id: totrans-85
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**利用AI优化mRNA结构和** **脂质纳米粒子**'
- en: '**Example**: AI’s predictive modeling can help Moderna’s researchers tailor
    the structure of mRNA molecules and the lipid nanoparticles that carry them. This
    could lead to improved stability, delivery, and efficacy of mRNA vaccines and
    therapies.'
  id: totrans-86
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：AI的预测建模可以帮助莫德纳的研究人员量身定制mRNA分子及其携带的脂质纳米粒子的结构。这可能会提高mRNA疫苗和疗法的稳定性、递送能力和疗效。'
- en: '**Predicting drug interactions with** **combination therapies**'
  id: totrans-87
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**预测药物相互作用与** **联合疗法**'
- en: '**Example**: AI could assist Moderna in designing combination therapies where
    mRNA vaccines are used alongside traditional pharmaceuticals. This may enhance
    the effectiveness of treatments for complex conditions such as HIV or hepatitis.'
  id: totrans-88
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：AI可以帮助莫德纳设计联合疗法，其中mRNA疫苗与传统药物一起使用。这可能会增强治疗复杂病症（如HIV或肝炎）的效果。'
- en: AI in Moderna’s clinical trials
  id: totrans-89
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: AI在莫德纳的临床试验中的应用
- en: 'It’s important to note that the speed and efficiency of clinical trials can
    be game-changers in drug development. In this subsection, we’ll explore how Moderna
    is leveraging AI to make its clinical trials more adaptive and responsive:'
  id: totrans-90
  prefs: []
  type: TYPE_NORMAL
  zh: 需要注意的是，临床试验的速度和效率可能会成为药物开发的游戏规则改变者。在这一小节中，我们将探讨莫德纳如何利用AI使其临床试验更加适应性强且响应迅速：
- en: '**Adaptive clinical** **trial design**'
  id: totrans-91
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**适应性临床** **试验设计**'
- en: '**Example**: Moderna could employ AI to create adaptive clinical trial designs,
    similar to what was used during the COVID-19 vaccine trials. This would allow
    for real-time adjustments in the trials based on interim data, potentially accelerating
    the development and approval process.'
  id: totrans-92
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：莫德纳可以利用AI创建适应性临床试验设计，类似于COVID-19疫苗试验中使用的设计。这将允许根据中期数据实时调整试验，可能加速开发和批准过程。'
- en: '**Patient recruitment** **and monitoring**'
  id: totrans-93
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**患者招募** **与监测**'
- en: '**Example**: AI-powered algorithms could help Moderna identify and recruit
    suitable patients for clinical trials. Once enrolled, AI monitoring could provide
    continuous assessment, improving safety and outcomes.'
  id: totrans-94
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：AI驱动的算法可以帮助莫德纳识别并招募适合临床试验的患者。一旦入组，AI监控可以提供持续的评估，从而改善安全性和疗效。'
- en: AI in Moderna’s pharmacovigilance and post-marketing surveillance
  id: totrans-95
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: AI在莫德纳的药物监测与上市后监督中的应用
- en: 'As you read on, consider that the journey of a drug doesn’t end when it hits
    the market. Here, we’ll delve into how Moderna uses AI to ensure ongoing safety
    and efficacy through pharmacovigilance and post-marketing surveillance:'
  id: totrans-96
  prefs: []
  type: TYPE_NORMAL
  zh: 在继续阅读时，请记住药物的旅程并不会在它进入市场时结束。在这里，我们将深入探讨Moderna如何利用人工智能通过药物警戒和上市后监测确保药物的持续安全性和有效性：
- en: '**Monitoring** **adverse effects**'
  id: totrans-97
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**监测** **不良反应**'
- en: '**Example**: AI systems could be deployed to monitor patient reactions to new
    drugs in real time, helping Moderna rapidly identify and respond to adverse effects,
    aligning with regulatory requirements and patient safety. For example, Moderna
    is collaborating with IBM to explore technologies, including AI, blockchain, and
    hybrid cloud, which could help support smarter COVID-19 vaccine management.'
  id: totrans-98
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：人工智能系统可以实时监测患者对新药的反应，帮助Moderna迅速识别并应对不良反应，确保符合监管要求并保障患者安全。例如，Moderna正在与IBM合作，探索包括人工智能、区块链和混合云在内的技术，这些技术可能有助于更智能地管理COVID-19疫苗。'
- en: '**Long-term** **efficacy analysis**'
  id: totrans-99
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**长期** **有效性分析**'
- en: '**Example**: Utilizing AI in long-term studies could allow Moderna to gauge
    the continued effectiveness of its therapies, a crucial aspect in supporting their
    continued use and potential repurposing. For example, a study found that the efficacy
    of Moderna’s COVID-19 vaccine peaked at 94% after 120 days.'
  id: totrans-100
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：在长期研究中利用人工智能可以让Moderna评估其疗法的持续有效性，这是支持其持续使用和潜在重定位的关键因素。例如，一项研究发现，Moderna的COVID-19疫苗在120天后效果达到94%。'
- en: AI in Moderna’s supply chain and manufacturing efficiency
  id: totrans-101
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: AI在Moderna供应链和制造效率中的应用
- en: 'As we transition from development to distribution, let’s explore how Moderna
    leverages AI to streamline its supply chain and optimize manufacturing. This section
    will show you the backend processes that ensure medicines are effectively produced
    and delivered:'
  id: totrans-102
  prefs: []
  type: TYPE_NORMAL
  zh: 随着我们从开发阶段过渡到分销阶段，接下来我们将探讨Moderna如何利用人工智能来简化供应链并优化制造过程。这一部分将展示确保药品有效生产和交付的后端流程：
- en: '**Predictive maintenance**'
  id: totrans-103
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**预测性维护**'
- en: '**Example**: AI could forecast when equipment in manufacturing facilities might
    fail, allowing for timely maintenance, thus ensuring continuous production and
    meeting demand. For example, McKinsey & Company has identified predictive maintenance
    as one of the most valuable ways to enhance a business’s maintenance-service organization
    and create value from analytics-based technologies.'
  id: totrans-104
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：人工智能可以预测制造设施中的设备何时可能出现故障，从而进行及时维护，确保生产的连续性并满足需求。例如，麦肯锡公司已经将预测性维护视为提升企业维护服务组织价值并通过基于分析的技术创造价值的最有价值的方式之一。'
- en: '**Demand forecasting**'
  id: totrans-105
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**需求预测**'
- en: '**Example**: AI algorithms could predict global demand for specific drugs,
    helping Moderna to optimize its supply chain and reduce costs. For example, Moderna
    has raised its sales forecast for its COVID-19 vaccine several times based on
    contracts already in place and anticipated demand.'
  id: totrans-106
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：人工智能算法可以预测特定药物的全球需求，帮助Moderna优化供应链并降低成本。例如，Moderna根据已有合同和预计需求多次上调其COVID-19疫苗的销售预期。'
- en: AI in Moderna’s drug development strategy
  id: totrans-107
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: AI在Moderna药物开发战略中的应用
- en: 'In this section, we’ll delve into the strategic advantages AI affords Moderna
    in extending and diversifying its drug portfolio. From reviving expiring patents
    to addressing underserved health areas, you’ll see how AI can be a game-changer
    in pharmaceutical strategy:'
  id: totrans-108
  prefs: []
  type: TYPE_NORMAL
  zh: 在这一部分，我们将深入探讨人工智能如何为Moderna在扩大和多样化药物组合方面提供战略优势。从延续过期专利到解决被忽视的健康问题，您将看到人工智能如何成为制药战略中的改变游戏规则的力量：
- en: '**Biosimilars and** **drug repurposing**'
  id: totrans-109
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**生物仿制药和** **药物重定位**'
- en: '**Example**: As patents on existing biological drugs expire, Moderna could
    use AI to design biosimilars, extending the life cycle of successful therapies.
    AI could also identify new applications for existing mRNA therapies, allowing
    Moderna to expand its product line without starting from scratch.'
  id: totrans-110
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：随着现有生物药物专利的到期，Moderna可以利用人工智能设计生物仿制药，延长成功疗法的生命周期。人工智能还可以识别现有mRNA疗法的新应用，使Moderna能够扩展其产品线，而无需从零开始。'
- en: '**Addressing** **neglected diseases**'
  id: totrans-111
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**解决** **被忽视的疾病**'
- en: '**Example**: Moderna could leverage AI to explore treatments for diseases often
    overlooked due to lack of profitability, such as tropical diseases. This aligns
    with Moderna’s commitment to global health and could open up new markets and partnerships.'
  id: totrans-112
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：Moderna可以利用人工智能探索针对因缺乏盈利性而常被忽视的疾病（如热带病）的治疗方案。这与Moderna致力于全球健康的承诺相一致，并可能开辟新的市场和合作机会。'
- en: Integration with quantum computing
  id: totrans-113
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 与量子计算的整合
- en: 'As we pivot to explore the fascinating intersection of quantum computing and
    AI, you’ll learn why this technology is pivotal for Moderna’s long-term innovation
    and investment potential. Quantum computing offers unprecedented computational
    capabilities, making it a key enabler for more advanced AI-driven drug discovery
    and design:'
  id: totrans-114
  prefs: []
  type: TYPE_NORMAL
  zh: 当我们转向探索量子计算与AI的迷人交集时，你将了解到为什么这项技术对Moderna的长期创新和投资潜力至关重要。量子计算提供了前所未有的计算能力，使其成为更先进的AI驱动药物发现和设计的关键推动力：
- en: '**Quantum-assisted** **molecular simulations**'
  id: totrans-115
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**量子辅助** **分子模拟**'
- en: '**Example**: In collaboration with IBM, Moderna could utilize quantum computing
    for rapid and accurate molecular simulations. This would provide deeper insights
    into how mRNA molecules interact with cellular machinery, guiding the design of
    more effective therapies.'
  id: totrans-116
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '**示例**：在与IBM的合作中，Moderna可以利用量子计算进行快速且准确的分子模拟。这将深入洞察mRNA分子如何与细胞机制相互作用，从而指导更有效治疗方法的设计。'
- en: The next section uncovers how Moderna has embraced AI as more than a tool but
    as the visionary artist and strategist behind their groundbreaking approach to
    medicine. From leveraging AI in the creation of novel mRNA constructs to utilizing
    generative AI with quantum computing, Moderna’s digital infusion has reshaped
    the very fabric of pharmaceutical exploration and medical care.
  id: totrans-117
  prefs: []
  type: TYPE_NORMAL
  zh: 下一部分揭示了Moderna如何将AI视为不仅仅是工具，而是其开创性医学方法背后的远见艺术家和战略家。从利用AI创建新型mRNA构造到结合量子计算与生成式AI，Moderna的数字化融入重新定义了制药探索和医疗护理的基础。
- en: The future reimagined – Moderna’s AI-driven symphony in medicine and biotechnology
  id: totrans-118
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 未来的重构——Moderna在医学和生物技术中的AI驱动交响曲
- en: In this section, we’ll delve into Moderna’s pioneering role in leveraging AI
    for transformative advancements in biotechnology. You’ll learn how Moderna seamlessly
    integrates AI into its business model, from drug discovery to manufacturing, and
    how it’s redefining the healthcare landscape. The purpose of this section is to
    provide investors and technologists with a comprehensive understanding of how
    AI serves as more than just a tool; it’s a creative force driving Moderna’s innovative
    strategies. This exploration offers valuable insights into the investment opportunities
    and prospects in the rapidly evolving intersection of AI and healthcare.
  id: totrans-119
  prefs: []
  type: TYPE_NORMAL
  zh: 在这一部分，我们将深入探讨Moderna在利用AI推动生物技术变革中的先锋角色。你将了解Moderna如何将AI无缝整合进其商业模式，从药物发现到生产制造，并且如何重新定义医疗健康领域的格局。本节的目的是为投资者和技术专家提供全面理解AI如何不仅仅作为工具，而是推动Moderna创新战略的创造性力量。此探索为在快速发展的AI与医疗交汇点上的投资机会和前景提供了宝贵见解。
- en: AI is not merely an enhancement to the field of medicine and drug discovery;
    it’s an unfolding revolution – a harmonious blend of precision, insight, creativity,
    empathy, and agility. AI’s role extends beyond challenging patents or merely supplementing
    human intellect; it magnifies our ability to heal, innovate, and reach the previously
    unreachable realms of healthcare.
  id: totrans-120
  prefs: []
  type: TYPE_NORMAL
  zh: AI不仅仅是医学和药物发现领域的增强工具；它是一场正在展开的革命——精确、洞察、创造力、同理心和敏捷性的和谐融合。AI的角色不仅仅是挑战专利或仅仅补充人类智慧；它放大了我们治疗、创新的能力，拓展了曾经无法触及的医疗领域。
- en: In an era dominated by data and a constant craving for innovation, AI stands
    as the catalytic force, a maestro conducting a symphony of pharmaceutical enlightenment.
    It transcends being just a game-changer; it’s defining the new game altogether.
    Welcome to the future of medicine, where AI morphs into the visionary artist,
    the strategist, the healer, and the herald of unexplored vistas.
  id: totrans-121
  prefs: []
  type: TYPE_NORMAL
  zh: 在一个数据主导并不断渴求创新的时代，AI作为催化力量屹立其中，犹如指挥家引领着制药启蒙的交响乐。它超越了单纯的游戏规则改变者；它正在重新定义整个游戏。欢迎进入医学的未来，在这里，AI蜕变为远见的艺术家、战略家、治愈者和未探索领域的先驱。
- en: In the upcoming subsections, we’ll delve into Moderna’s symbiotic relationship
    with cutting-edge technologies such as AI and quantum computing. You’ll discover
    how strategic collaborations with tech giants such as IBM serve as catalysts for
    innovation in mRNA medicine. We’ll also examine the robust digital infrastructure
    that empowers Moderna to redefine traditional approaches to drug development.
    Finally, we’ll reveal how these technological synergies extend beyond the lab,
    shaping Moderna’s organizational culture and long-term strategic planning.
  id: totrans-122
  prefs: []
  type: TYPE_NORMAL
  zh: 在接下来的几个小节中，我们将深入探讨Moderna与前沿技术如AI和量子计算的共生关系。你将发现，Moderna如何通过与IBM等科技巨头的战略合作，成为mRNA药物创新的催化剂。我们还将审视支持Moderna重新定义传统药物研发方法的强大数字基础设施。最后，我们将揭示这些技术协同效应如何超越实验室，塑造Moderna的组织文化和长期战略规划。
- en: Moderna – orchestrating the AI symphony in biotechnology
  id: totrans-123
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: Moderna —— 在生物技术中指挥AI交响乐
- en: Moderna, since its inception in 2010, has embodied this symphonic embrace of
    technology. Born in the **Amazon Web Services** (**AWS**) cloud, it crafted its
    entire drug discovery and manufacturing process around digitalization, seamlessly
    infused by AI.
  id: totrans-124
  prefs: []
  type: TYPE_NORMAL
  zh: 自2010年创立以来，Moderna便体现了这种技术的交响式融合。作为**亚马逊云服务**（**AWS**）的一部分，它围绕数字化构建了整个药物发现与制造过程，并巧妙地融入了AI技术。
- en: Moderna’s business model, primarily fueled by product sales, grants, and collaboration
    agreements, has harnessed its *AI factory* to redefine the way diseases are combated.
    It has employed Generative AI, which describes algorithms capable of crafting
    new content from trained data, to propel its groundbreaking mRNA technology.
  id: totrans-125
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna的商业模式，主要由产品销售、资助和合作协议推动，已经利用其*AI工厂*重新定义了对抗疾病的方式。它运用了生成性AI技术，这种算法能够从训练数据中创造出新的内容，以推动其开创性的mRNA技术。
- en: The collaboration with IBM – a milestone in innovation
  id: totrans-126
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 与IBM的合作 —— 创新的一座里程碑
- en: In April 2023, a remarkable alliance between Moderna and IBM was forged, aiming
    to harness Generative AI and quantum computing to further advance mRNA technology.
    This agreement facilitated Moderna’s access to IBM’s advanced quantum computing
    systems and generative AI models. The collaboration’s objective was to unravel
    “the characteristics of potential mRNA medicines,” paving the way for a new era
    of vaccines and therapies.
  id: totrans-127
  prefs: []
  type: TYPE_NORMAL
  zh: 2023年4月，Moderna与IBM达成了一项卓越的合作伙伴关系，旨在利用生成性AI和量子计算技术进一步推动mRNA技术的发展。此次协议使Moderna能够接触到IBM的先进量子计算系统和生成性AI模型。合作的目标是揭示“潜在mRNA药物的特性”，为疫苗和治疗新纪元铺平道路。
- en: Digital infrastructure – a backbone of innovation
  id: totrans-128
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 数字基础设施 —— 创新的支柱
- en: Moderna’s platform thrives on its robust digital infrastructure, which marries
    workflow automation, data capture, and AI to quicken processes and furnish insights
    to its researchers. Unique to Moderna’s approach is the parallelization of drug
    development stages, usually pursued sequentially, thus redefining efficiency.
  id: totrans-129
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna的平台依托其强大的数字基础设施，结合了工作流自动化、数据采集和AI，以加快流程并为研究人员提供深刻洞察。Moderna的方法独特之处在于将通常按顺序进行的药物研发阶段并行化，从而重新定义了效率。
- en: A testament to Moderna’s innovative spirit is its self-crafted drug design studio,
    hosted on AWS Fargate. This web-based application enables scientists to create
    novel mRNA constructs, optimize them using AI algorithms, and then forward them
    to their high-throughput preclinical scale production line. Thousands of unique
    mRNA constructs, including the renowned COVID-19 vaccine, stand as evidence of
    this groundbreaking approach.
  id: totrans-130
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna创新精神的见证之一是其自主打造的药物设计工作室，托管在AWS Fargate上。这个基于Web的应用程序使科学家能够创建新的mRNA构建体，通过AI算法优化它们，然后将其送往高通量的临床前生产线。数千个独特的mRNA构建体，包括著名的COVID-19疫苗，作为这一开创性方法的证据。
- en: Moderna’s exploration of AI in medicine is akin to a well-orchestrated concerto,
    where various technological components play in unison to compose a melody of innovation.
    This AI-driven journey, marked by significant milestones and strategic collaborations,
    paints a vivid picture of the future. It highlights a world where technology isn’t
    merely a tool but an artist weaving the tapestry of modern medicine, providing
    glimpses of what the future could hold. It’s more than a strategy; it’s a philosophy,
    embodying a novel perspective on investing in a domain where biology and technology
    merge as the frontiers of human advancement.
  id: totrans-131
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna在医学中对AI的探索，犹如一场精心编排的协奏曲，其中各种技术组件和谐共鸣，奏响创新的旋律。这一由AI驱动的旅程，标志着重大的里程碑和战略合作，生动勾画了未来的画面。它突显了一个世界，在这个世界中，技术不仅仅是工具，而是艺术家，编织着现代医学的锦缎，提供了对未来可能的展望。这不仅仅是一种战略，它是一种哲学，体现了在生物学与技术融合这一人类进步的前沿领域中，投资的全新视角。
- en: The synergies between Moderna’s partnerships with IBM and CMU extend beyond
    mere technological enhancement. The next section reveals a comprehensive approach
    that aligns technological innovation with organizational culture, workforce development,
    and long-term strategy.
  id: totrans-132
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna与IBM以及CMU的合作所产生的协同效应，超越了单纯的技术提升。下一节将揭示一种全面的方法，将技术创新与组织文化、员工发展和长期战略相结合。
- en: In this section, we’ve explored the integration of AI and quantum computing
    in Moderna’s operations, spanning from drug discovery to manufacturing. We examined
    how these technologies not only accelerate research but also offer strategic advantages,
    including adaptive clinical trial designs and optimized supply chain management.
    Understanding these synergies is crucial for investors and technologists looking
    at opportunities in the dynamic intersection of biotech, AI, and finance. This
    deep dive provided a holistic view of how Moderna is not just using technology
    as a tool but integrating it into the very fabric of its innovative approach to
    medicine.
  id: totrans-133
  prefs: []
  type: TYPE_NORMAL
  zh: 在这一部分，我们探讨了AI与量子计算在Moderna运营中的整合，涵盖了从药物发现到生产制造的各个方面。我们分析了这些技术如何不仅加速了研究进程，还提供了战略优势，包括适应性临床试验设计和优化的供应链管理。了解这些协同效应，对于那些在生物技术、AI和金融的动态交汇处寻找机会的投资者和技术人员来说至关重要。这次深度剖析提供了Moderna如何不仅将技术作为工具，而是将其融入其创新医学方法的整体视角。
- en: A new chapter – the Moderna-IBM partnership
  id: totrans-134
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 新篇章——Moderna与IBM的合作伙伴关系
- en: In this section, we will unpack the groundbreaking partnership between Moderna
    and IBM, a fusion of quantum computing and AI that’s reshaping healthcare. You’ll
    learn how quantum tech speeds up drug discovery, while AI fine-tunes mRNA medicines.
    While the Moderna-IBM partnership may initially seem unrelated to ChatGPT, finance,
    and Power BI, the underlying technologies – quantum computing and AI – offer key
    takeaways. By understanding this partnership, you can better appreciate the transformative
    potential of these technologies in diverse fields, including finance and data
    analytics. By the end, you’ll grasp why this alliance is a game-changer in medical
    innovation and how it sets new benchmarks for the industry.
  id: totrans-135
  prefs: []
  type: TYPE_NORMAL
  zh: 在这一部分，我们将解读Moderna与IBM之间的突破性合作伙伴关系，这是一种量子计算与AI的融合，正在重塑医疗保健。你将了解量子技术如何加速药物发现，同时AI如何精细调优mRNA药物。尽管Moderna与IBM的合作关系最初看似与ChatGPT、金融和Power
    BI无关，但其背后的技术——量子计算和AI——却提供了关键的启示。通过了解这一合作伙伴关系，你可以更好地理解这些技术在包括金融和数据分析在内的各个领域的变革潜力。到最后，你将明白为何这一联盟在医学创新中是一次颠覆性变革，并且它如何为行业树立了新的标杆。
- en: This collaboration exemplifies another milestone in Moderna’s pursuit of excellence.
    It presents a fusion of intelligence and innovation, where quantum computing and
    AI converge to pave the way for groundbreaking discoveries. The synergy between
    Moderna and IBM sets the stage for an exciting future, one where the potential
    to redefine medicine and accelerate the delivery of life-changing treatments to
    patients is not just a vision but a tangible reality.
  id: totrans-136
  prefs: []
  type: TYPE_NORMAL
  zh: 这一合作展示了Moderna追求卓越的又一里程碑。它呈现了一种智能与创新的融合，量子计算与AI的结合为突破性发现铺平了道路。Moderna与IBM之间的协同效应为激动人心的未来奠定了基础，一个未来在这里，重新定义医学的潜力和加速改变患者生命的治疗交付，不仅是愿景，而是触手可及的现实。
- en: In the upcoming subsection, we’ll explore *advanced drug discovery*, detailing
    how quantum computing and AI are expediting the drug development process. Next,
    we’ll delve into the *optimization of mRNA medicines*, showing how predictive
    models can fine-tune the effectiveness and safety of treatments. We’ll also cover
    *workforce development* and *access to cutting-edge technology*, emphasizing the
    strategic benefits of investing in a quantum-ready workforce and technology alliances.
    Understanding these elements is crucial as they demonstrate the real-world applications
    of advanced technologies, offering actionable insights that can be applied to
    financial analysis, predictive modeling in Power BI, and understanding the generative
    capabilities of AI, such as ChatGPT.
  id: totrans-137
  prefs: []
  type: TYPE_NORMAL
  zh: 在接下来的小节中，我们将探索 *先进药物发现*，详细说明量子计算和 AI 如何加速药物开发过程。接下来，我们将深入探讨 *mRNA 药物的优化*，展示预测模型如何微调治疗的效果和安全性。我们还将涵盖
    *劳动力发展* 和 *访问尖端技术*，强调投资量子准备劳动力和技术联盟的战略性利益。理解这些要素至关重要，因为它们展示了先进技术的实际应用，提供了可应用于财务分析、Power
    BI 中的预测建模以及理解 AI 生成能力（如 ChatGPT）的可操作见解。
- en: IBM partnership – quantum computing and AI
  id: totrans-138
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: IBM 合作伙伴关系 – 量子计算与 AI
- en: 'Let’s dive into a multifaceted exploration of how Moderna is leveraging advanced
    technologies and partnerships to redefine the healthcare landscape. From the accelerated
    pace of drug discovery through quantum computing and AI, to workforce development
    and strategic collaborations, this subsection offers a panoramic view of the innovations
    shaping not just medicine, but the future of biotechnology itself:'
  id: totrans-139
  prefs: []
  type: TYPE_NORMAL
  zh: 让我们深入探索 Moderna 如何利用先进技术和合作伙伴关系重新定义医疗健康格局。从通过量子计算和 AI 加速药物发现的步伐，到劳动力发展和战略合作，本小节提供了一个全景视角，展示了不仅是医学，还包括生物技术未来的创新：
- en: '**Advanced** **drug discovery**:'
  id: totrans-140
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**先进的** **药物发现**：'
- en: '**Quantum computing**: By harnessing IBM’s quantum computing capabilities,
    Moderna can perform complex molecular simulations, a previously time-consuming
    task, at a rapid pace. This may accelerate the transition from identifying drug
    targets to testing viable candidates.'
  id: totrans-141
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**量子计算**：通过利用 IBM 的量子计算能力，Moderna 可以快速进行复杂的分子模拟，这在过去是一个耗时的任务。这可能会加速从识别药物靶点到测试可行候选药物的过渡。'
- en: '**AI integration**: With IBM’s AI, particularly generative models for therapeutics,
    Moderna has an opportunity to delve deeper into understanding how molecules behave
    and even create entirely new ones.'
  id: totrans-142
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**AI 集成**：借助 IBM 的人工智能，特别是用于治疗的生成模型，Moderna 有机会深入了解分子的行为，甚至创造全新的分子。'
- en: '**Optimization of** **mRNA medicines**:'
  id: totrans-143
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**mRNA 药物的优化**：'
- en: '**Predictive modeling**: Using AI foundation models such as MoLFormer, Moderna
    can make precise predictions about molecules’ properties. This will inform the
    development of lipid nanoparticles and mRNA, improving safety and effectiveness.'
  id: totrans-144
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**预测建模**：通过使用像 MoLFormer 这样的 AI 基础模型，Moderna 可以精确预测分子的特性。这将有助于脂质纳米粒子和 mRNA
    的开发，提高安全性和效果。'
- en: '**Workforce development**:'
  id: totrans-145
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**劳动力发展**：'
- en: '**Quantum-ready workforce**: By investing in building a quantum-ready workforce,
    Moderna ensures that it is prepared to leverage this emerging technology, positioning
    itself as an early adopter in the biotech industry'
  id: totrans-146
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**量子准备的劳动力**：通过投资建设量子准备的劳动力，Moderna 确保自己能够利用这一新兴技术，将自己定位为生物技术行业的早期采纳者。'
- en: '**Access to** **cutting-edge technology**:'
  id: totrans-147
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**访问** **尖端技术**：'
- en: '**IBM quantum network**: Participation in this network grants Moderna access
    to the forefront of quantum technologies, providing a competitive edge in the
    exploration of innovative life sciences applications'
  id: totrans-148
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**IBM 量子网络**：参与该网络使 Moderna 可以接触到量子技术的最前沿，在探索创新生命科学应用方面提供了竞争优势。'
- en: '**Synthesis with** **mRNA technology**:'
  id: totrans-149
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**与** **mRNA 技术的合成**：'
- en: '**Complementary strength**: The strengths of quantum computing and AI align
    seamlessly with Moderna’s cornerstone of mRNA technology. The integration enhances
    the company’s existing strengths and opens up novel opportunities in therapeutics.'
  id: totrans-150
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**互补优势**：量子计算和 AI 的优势与 Moderna 的 mRNA 技术基石无缝对接。技术集成增强了公司现有的优势，并为治疗学开辟了新的机会。'
- en: The next section highlights another partnership between Moderna and CMU to create
    an immersive learning experience for its employees. We will explore the AI Academy’s
    inception, purpose, curriculum, and potential to transform the way mRNA medicines
    are brought to patients.
  id: totrans-151
  prefs: []
  type: TYPE_NORMAL
  zh: 下一节将重点介绍Moderna与CMU之间的另一项合作，旨在为其员工创造身临其境的学习体验。我们将探讨AI学院的起源、目的、课程和它在改变mRNA药物进入患者手中的方式方面的潜力。
- en: Moderna’s AI Academy – a partnership with CMU for technological innovation
  id: totrans-152
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: Moderna的AI学院——与CMU合作推动技术创新
- en: Let’s dive into the revolutionary alliance between Moderna and Carnegie Mellon
    University, a partnership that seamlessly translates theoretical AI into practical,
    groundbreaking applications while serving as an inspirational blueprint for those
    wanting to learn more about how to integrate ChatGPT into finance use cases. This
    section illustrates how an educated, AI-literate workforce can not only accelerate
    areas such as drug discovery but also redefine the boundaries for fields such
    as finance and data visualization. If you’ve been hesitant to invest in emerging
    technologies, consider this your call to action. By adopting a calculated, educational
    approach to AI, you’re not merely staying ahead of technological trends – you’re
    reshaping them. Envision a future where you too can embed AI and machine learning
    into the very fabric of your organization’s DNA.
  id: totrans-153
  prefs: []
  type: TYPE_NORMAL
  zh: 让我们深入探讨Moderna与卡内基梅隆大学之间的革命性联盟，这一合作将理论AI无缝转化为实际的突破性应用，同时为那些希望了解如何将ChatGPT整合到金融应用中的人提供了灵感蓝图。本节将展示一个受过教育、具有AI素养的员工队伍，如何不仅加速药物发现等领域的发展，还能重新定义金融和数据可视化等领域的边界。如果你一直对投资新兴技术犹豫不决，那么请将此视为你的行动号召。通过采取一种计算和教育性的AI方法，你不仅是站在技术趋势的前沿——你还在重新塑造这些趋势。设想一个未来，你也能将AI和机器学习嵌入到你所在组织的DNA中。
- en: Moderna has launched the **AI Academy** in partnership with **CMU**. The AI
    Academy is an innovative initiative that will bring to life an immersive learning
    experience for Moderna employees. The goal of the AI Academy is to educate and
    empower employees at all levels to identify and integrate AI and machine learning
    solutions into every Moderna system and process to bring mRNA medicines to patients.
  id: totrans-154
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna与**CMU**合作推出了**AI学院**。AI学院是一个创新举措，将为Moderna员工带来身临其境的学习体验。AI学院的目标是教育和赋能各级员工，帮助他们识别并将AI和机器学习解决方案整合到Moderna的每一个系统和流程中，以将mRNA药物带给患者。
- en: Get ready to embark on a journey through Moderna’s strategic approach to AI
    adoption and workforce transformation. In the following subsections, you’ll learn
    how the biotech giant is not only cultivating a culture rich in AI literacy but
    also leveraging AI’s transformative power to enhance drug discovery and optimize
    operations. More than just tools, these advanced technologies become an integral
    part of Moderna’s business fabric, setting the stage for ethical and impactful
    AI use.
  id: totrans-155
  prefs: []
  type: TYPE_NORMAL
  zh: 准备好开始一段旅程，了解Moderna如何战略性地采用AI，并转型其员工队伍。在接下来的小节中，你将了解这家生物技术巨头是如何不仅培养AI素养丰富的文化，还利用AI的变革力量来增强药物发现并优化运营的。这些先进技术不仅仅是工具，它们已经成为Moderna商业结构的不可或缺的一部分，为伦理且有影响力的AI使用奠定了基础。
- en: Moderna’s AI Academy in partnership with CMU
  id: totrans-156
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: Moderna与CMU合作的AI学院
- en: 'Let’s explore everything from building a digitally literate workforce to leveraging
    AI for groundbreaking advancements in drug discovery. You’ll also discover how
    Moderna is future-proofing its workforce while adhering to a strong ethical framework.
    It’s a masterclass on how to seamlessly integrate technology into an organization:'
  id: totrans-157
  prefs: []
  type: TYPE_NORMAL
  zh: 让我们从建设一个数字化素养的员工队伍到利用AI在药物发现方面实现突破性进展，探索一切。你还将发现Moderna如何在遵循强有力的伦理框架的同时，为未来做好员工队伍的准备。这是关于如何将技术无缝整合到组织中的一堂大师课：
- en: '**Broad-based** **AI literacy**:'
  id: totrans-158
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**广泛的** **AI素养**：'
- en: '**Building AI culture**: This initiative will help infuse AI literacy across
    Moderna’s workforce. It aligns with the company’s collaboration with IBM as both
    require a foundation of understanding AI’s potential applications.'
  id: totrans-159
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**构建AI文化**：这一举措将帮助在Moderna的员工中普及AI素养。这与公司与IBM的合作相一致，因为两者都需要建立理解AI潜在应用的基础。'
- en: '**Enhanced drug discovery and** **process optimization**:'
  id: totrans-160
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**增强的药物发现和** **流程优化**：'
- en: '**Applying AI across functions**: From drug discovery to automating tasks and
    optimizing resource use, this educational partnership helps Moderna leverage AI
    throughout the organization'
  id: totrans-161
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**在各职能部门应用AI**：从药物发现到自动化任务和资源优化，这一教育合作伙伴关系帮助Moderna在整个组织中推广AI的应用'
- en: '**Workforce upskilling** **and futureproofing**:'
  id: totrans-162
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**员工技能提升** **与未来保障**：'
- en: '**Investment in employees**: By providing top-notch learning opportunities,
    Moderna strengthens employee retention and prepares its workforce for a future
    where digital technologies are central'
  id: totrans-163
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**投资员工**：通过提供一流的学习机会，Moderna增强了员工的留任率，并为未来数字技术占主导地位的工作环境做好准备'
- en: '**Alignment with ethics**: Including AI ethics ensures responsible AI use,
    aligning with Moderna’s commitment to integrity and social responsibility'
  id: totrans-164
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**符合伦理标准**：包括AI伦理确保负责任地使用AI，符合Moderna对诚信和社会责任的承诺'
- en: This key partnership enables Moderna to create a roadmap for the future where
    advanced technologies such as AI are not just tools but integrated components
    of the business model. They align with Moderna’s mission, enhance its strengths,
    mitigate some of its weaknesses, and position the company at the forefront of
    technology-driven breakthroughs in the biotechnology and pharmaceutical sectors.
  id: totrans-165
  prefs: []
  type: TYPE_NORMAL
  zh: 这一关键合作伙伴关系使Moderna能够制定出一条未来的发展路线图，未来先进技术如AI不仅是工具，而是商业模式的整合组件。它们与Moderna的使命相契合，增强其优势，弥补其某些弱点，并将公司置于生物技术和制药行业技术驱动突破的前沿。
- en: The next section delves into Moderna’s endeavors to create a future where pandemics
    may no longer instill fear, exploring their work in crafting multi-valent vaccines,
    rapid response plans, broad-spectrum antiviral drugs, and collaborations with
    global health authorities.
  id: totrans-166
  prefs: []
  type: TYPE_NORMAL
  zh: 下一部分深入探讨Moderna的努力，旨在创造一个大流行不再令人恐惧的未来，探索他们在制定多价疫苗、快速响应计划、广谱抗病毒药物以及与全球卫生机构的合作方面的工作。
- en: Confronting future pandemics – Moderna’s innovation in multi-valent vaccines
    and AI-driven antivirals
  id: totrans-167
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 面对未来的大流行——Moderna在多价疫苗和AI驱动抗病毒药物方面的创新
- en: In this section, you’ll unravel how the convergence of mRNA technology and AI
    is breaking the mold in multi-valent vaccines and antiviral drugs. Equally riveting
    is how Moderna’s AI-augmented strategies are relevant to those interested in using
    ChatGPT for finance and Power BI applications. Just as Moderna is synthesizing
    vast genetic datasets to predict optimal mRNA sequences, imagine using similar
    AI-powered methods to decode financial markets or create dynamic Power BI visualizations.
    We’re peeling back the curtain on a future where AI is the linchpin of both medical
    innovation and financial analytics.
  id: totrans-168
  prefs: []
  type: TYPE_NORMAL
  zh: 在这一部分，你将揭示mRNA技术与AI如何打破常规，推动多价疫苗和抗病毒药物的发展。同样引人入胜的是，Moderna的AI增强策略如何与那些希望使用ChatGPT进行金融分析和Power
    BI应用的人产生关联。正如Moderna正在合成庞大的基因数据集来预测最佳的mRNA序列，可以想象，使用类似的AI驱动方法来解码金融市场或创建动态的Power
    BI可视化图表。我们正揭开未来的面纱，AI将在医疗创新和金融分析中发挥核心作用。
- en: Moderna, a pioneering force in the biotechnology space, is transforming the
    landscape of vaccine development by integrating AI and computational biology.
    They are working to create not just vaccines for specific diseases but revolutionary
    broad-spectrum solutions that could counter multiple threats.
  id: totrans-169
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna，作为生物技术领域的先驱力量，正通过将AI和计算生物学融入其中，改变疫苗研发的格局。他们不仅在开发针对特定疾病的疫苗，而且在努力创造革命性的广谱解决方案，以应对多重威胁。
- en: 'Moderna is investigating a potential vaccine that can put the five needed mRNAs
    in one lipid nanoparticle to make a vaccine that targets all subunits. Other combinations
    can also be created in mRNA vaccines. For example, a multi-valent vaccine can
    attack multiple strains of the same disease or even different diseases:'
  id: totrans-170
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna正在研究一种潜在的疫苗，可以将五种所需的mRNA放入一个脂质纳米粒子中，从而制造出一种针对所有亚单位的疫苗。mRNA疫苗还可以创造其他组合。例如，多价疫苗可以攻击同一种疾病的多个毒株，甚至不同的疾病：
- en: '**mRNA technology and AI collaboration**: Moderna is exploring the fascinating
    concept of crafting a vaccine that houses multiple mRNAs within one lipid nanoparticle.
    This *multi-valent* vaccine could target multiple strains of the same disease
    or even different diseases simultaneously. Utilizing AI algorithms, they analyze
    vast datasets of viral genetic information to predict optimal mRNA sequences.'
  id: totrans-171
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**mRNA技术与AI合作**：Moderna正在探索一个令人着迷的概念，即在一个脂质纳米粒子中装载多种mRNA，从而制造一种疫苗。这种*多价*疫苗可以同时针对同一种疾病的多种毒株，甚至不同的疾病。通过利用AI算法，他们分析大量病毒基因数据集，预测最佳的mRNA序列。'
- en: '**Rapid response plans**: In the face of an emerging health crisis, time is
    of the essence. Moderna’s investment in AI accelerates the design phase, allowing
    it to create, test, and iterate on vaccine prototypes with unprecedented speed.
    During the COVID-19 pandemic, this technology allowed Moderna to reach the clinical
    trial stage within a matter of months – a remarkable achievement.'
  id: totrans-172
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**快速响应计划**：面对突发的健康危机，时间至关重要。Moderna在人工智能上的投资加速了设计阶段，使其能够以前所未有的速度创建、测试和迭代疫苗原型。在COVID-19大流行期间，这项技术使Moderna在几个月内就进入了临床试验阶段——这一成就令人瞩目。'
- en: '**Prevention strategies**: AI plays an instrumental role in Moderna’s global
    surveillance systems for monitoring viral mutations and emerging threats. Predictive
    analytics tools offer foresight, enabling Moderna to pre-emptively develop vaccines
    or modify existing ones by following evolving viral landscapes.'
  id: totrans-173
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**预防策略**：人工智能在Moderna全球监测系统中发挥着关键作用，用于监控病毒变异和新兴威胁。预测分析工具提供前瞻性视角，使Moderna能够预先开发疫苗或修改现有疫苗，以应对不断变化的病毒格局。'
- en: '**Broad-spectrum antiviral drugs**: Beyond vaccines, Moderna is probing into
    the exciting realm of broad-spectrum antiviral drugs that could treat a variety
    of infections. They are harnessing machine learning algorithms to identify common
    molecular targets across different viruses, aiming to design drugs that could
    be akin to a universal defense mechanism against various viral diseases.'
  id: totrans-174
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**广谱抗病毒药物**：除了疫苗外，Moderna还在探索广谱抗病毒药物这一激动人心的领域，这些药物可以治疗多种感染。他们正在利用机器学习算法识别不同病毒之间的共同分子靶点，旨在设计出类似于针对各种病毒性疾病的普遍防御机制的药物。'
- en: '**Collaboration with global health authorities**: Moderna’s commitment to leveraging
    AI isn’t confined to laboratories. They work closely with global health authorities,
    sharing insights and collaborating on global strategies to ensure that these innovations
    benefit populations around the world.'
  id: totrans-175
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**与全球卫生机构的合作**：Moderna致力于利用人工智能的努力并不限于实验室。他们与全球卫生机构密切合作，分享见解并共同制定全球战略，确保这些创新能够惠及世界各地的民众。'
- en: By synthesizing the precise genetic engineering of mRNA with the predictive
    capabilities of AI, Moderna is forging a future where the term *pandemic* might
    lose its terror. The marriage of these technologies opens unprecedented avenues
    in the fight against infectious diseases, offering hope that humanity may be better
    prepared for the unforeseen challenges of tomorrow.
  id: totrans-176
  prefs: []
  type: TYPE_NORMAL
  zh: 通过将mRNA的精准基因工程与人工智能的预测能力相结合，Moderna正在打造一个未来，其中*大流行*一词可能会失去它的恐惧感。这些技术的结合为抗击传染病开辟了前所未有的途径，提供了希望，表明人类或许能更好地应对明日的不可预见挑战。
- en: Moderna, a key player in the global health sphere, is leveraging its trailblazing
    mRNA technology to advance cancer treatment. With a strategy that extends from
    early detection to personalized vaccines, the company aims to reshape oncology,
    promising a future where cancer can be tackled at its root. The next section delves
    into the visionary approach and groundbreaking work that put Moderna at the forefront
    of a potential revolution in cancer care.
  id: totrans-177
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna，全球卫生领域的关键参与者，正在利用其开创性的mRNA技术推动癌症治疗。公司从早期检测到个性化疫苗的战略，旨在重塑肿瘤学，承诺在未来能够从根本上应对癌症。下一节将深入探讨这一具有远见的方法及其开创性的工作，这使得Moderna站在了癌症治疗潜在革命的最前沿。
- en: Revolutionizing cancer care – Moderna’s mRNA ambitions in oncology
  id: totrans-178
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 革新癌症治疗——Moderna在肿瘤学领域的mRNA雄心
- en: Moderna CEO, Stéphane Bancel, has unveiled an ambitious vision for the company’s
    future in oncology, using mRNA technology to create personalized cancer vaccines.
    Recent mid-stage studies in skin cancer have shown promising results, and partnerships
    with leading companies such as Illumina’s Grail, Exact Sciences, and Freenome
    are fueling this mission with innovative diagnostic tools such as liquid biopsies.
  id: totrans-179
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna首席执行官Stéphane Bancel提出了公司在肿瘤学领域的雄心壮志，利用mRNA技术创造个性化癌症疫苗。近期在皮肤癌的中期研究显示出良好的结果，与Illumina的Grail、Exact
    Sciences和Freenome等领先公司建立的合作伙伴关系，通过液体活检等创新诊断工具推动这一使命。
- en: Bancel’s plan integrates liquid biopsies into routine physical check-ups, enabling
    early cancer detection and the development of custom vaccines to eradicate cancer
    at its inception. While acknowledging the need for further research and validation,
    Bancel is confident that Moderna’s financial backing can fuel a revolutionary
    change in cancer treatment, on par with or even surpassing recent breakthroughs
    like checkpoint inhibitors.
  id: totrans-180
  prefs: []
  type: TYPE_NORMAL
  zh: 班塞尔的计划将液体活检纳入常规体检，从而实现早期癌症检测并开发定制疫苗以消除癌症的初期阶段。尽管承认仍需要进一步的研究和验证，班塞尔确信，莫德纳的资金支持能够推动癌症治疗的革命性变革，达到或甚至超越像检查点抑制剂这样的最新突破。
- en: The global oncology market, valued at over $203.42 billion in 2022 and expected
    to reach $470.61 billion by 2032, offers significant opportunities for Moderna’s
    pioneering work. According to articles in reputable journals such as Nature, the
    average global pipeline asset peak sales in oncology are projected to be substantial.
    Moderna’s current development pipeline includes several mRNA therapeutics and
    vaccines for oncology, rare liver diseases, and more. Their personalized cancer
    vaccine is in phase 2 trials, and multiple rare disease programs are advancing,
    reflecting Moderna’s strong positioning in these promising markets.
  id: totrans-181
  prefs: []
  type: TYPE_NORMAL
  zh: 全球肿瘤学市场在2022年的估值超过2034.2亿美元，预计到2032年将达到4706.1亿美元，为莫德纳的开创性工作提供了重大机遇。根据《自然》等权威期刊的文章，全球肿瘤学管线资产的平均峰值销售额预计将非常可观。莫德纳目前的开发管线包括多种mRNA治疗药物和癌症、罕见肝病等领域的疫苗。其个性化癌症疫苗正在进行第二阶段临床试验，多个罕见病项目也在推进中，显示出莫德纳在这些有前景市场中的强大定位。
- en: Moderna is leading the way in harnessing the power of mRNA technology to forge
    innovative solutions in medicine. From personalized cancer vaccines to global
    delivery networks, the company is exploring groundbreaking territories in genetic
    editing, AI-driven drug discovery, regenerative medicine, and rare disease therapies.
    The next section explores the vast potential and challenges of these initiatives,
    painting an exciting picture of a future where medicine transcends traditional
    boundaries.
  id: totrans-182
  prefs: []
  type: TYPE_NORMAL
  zh: 莫德纳在利用mRNA技术推动医学创新方面处于领先地位。从个性化癌症疫苗到全球配送网络，公司正在探索基因编辑、人工智能驱动的药物发现、再生医学以及罕见病治疗等开创性领域。下一部分将探讨这些举措的巨大潜力与挑战，勾画出一个医学超越传统界限的未来。
- en: The brave new world of medicine – Moderna’s pioneering path to personalized
    therapies
  id: totrans-183
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 医学的勇敢新世界——莫德纳开创个性化疗法的先锋之路
- en: 'Unlock the doors to the medical future you’ve only dreamed of in this captivating
    section on Moderna’s daring journey into personalized therapies. From custom-built
    cancer vaccines to awe-inspiring gene editing breakthroughs, this is your gateway
    to understanding how Moderna is revolutionizing medicine and why you can’t afford
    to miss out on these transformative insights:'
  id: totrans-184
  prefs: []
  type: TYPE_NORMAL
  zh: 在这一引人入胜的部分，解锁你梦寐以求的医疗未来，探索莫德纳在个性化疗法领域的大胆旅程。从量身定制的癌症疫苗到令人叹为观止的基因编辑突破，这里是你了解莫德纳如何革新医学的门户，并揭示为什么你不能错过这些变革性洞察的机会：
- en: '**Personalized cancer vaccines**: Imagine a world where cancer treatment is
    a precise, personalized weapon. Moderna’s ability to sequence a patient’s cancer
    genome could enable custom vaccines to train the immune system against individual
    cancer cells. Despite considerable challenges, this path represents a transformative
    leap toward conquering cancer.'
  id: totrans-185
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**个性化癌症疫苗**：想象一个癌症治疗是精确且个性化的武器的世界。莫德纳通过对患者癌症基因组的测序，可能使定制疫苗训练免疫系统对抗个别癌细胞。尽管面临诸多挑战，这一途径代表了向征服癌症迈出的变革性飞跃。'
- en: '**Gene editing therapies**: Science fiction no longer, Moderna’s expertise
    in mRNA technology may lead to breakthroughs in gene editing, including the utilization
    of CRISPR-Cas9\. The possibilities are extraordinary, from correcting rare genetic
    disorders to navigating complex ethical landscapes. Moderna’s role could be pivotal
    in shaping this brave new world of genetic medicine.'
  id: totrans-186
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**基因编辑疗法**：不再是科幻小说，莫德纳在mRNA技术方面的专长可能引领基因编辑的突破，包括CRISPR-Cas9的应用。其潜力非凡，从修正罕见基因疾病到处理复杂的伦理问题，莫德纳在塑造这一勇敢新世界的基因医学中可能发挥关键作用。'
- en: '**Collaboration with tech companies for AI-driven drug discovery**: By joining
    forces with tech giants such as Google DeepMind, Microsoft’s Project Hanover,
    NVIDIA, and Palantir, Moderna could usher in a new era of precision medicine.
    These collaborations could accelerate drug discovery and propel Moderna’s ambitions
    in personalized oncology.'
  id: totrans-187
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**与科技公司合作进行AI驱动的药物发现**：通过与谷歌DeepMind、微软Project Hanover、NVIDIA和Palantir等科技巨头合作，莫德纳可能会开创精准医疗的新纪元。这些合作可以加速药物发现，并推动莫德纳在个性化肿瘤学方面的雄心。'
- en: '**Regenerative medicine**: Moderna’s exploration into regenerative medicine
    could stimulate the body’s natural repair mechanisms. While the challenges are
    immense, the rewards – such as regenerating heart tissue or restoring spinal cord
    functions – are unprecedented.'
  id: totrans-188
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**再生医学**：莫德纳对再生医学的探索可能激活身体的自然修复机制。尽管面临巨大挑战，但其回报——如再生心脏组织或恢复脊髓功能——是前所未有的。'
- en: '**Rare disease therapies**: For those with rare genetic diseases, Moderna’s
    focus on targeted mRNA therapies offers transformative hope, paving the way for
    treatments that could change lives.'
  id: totrans-189
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**罕见病疗法**：对于那些患有罕见遗传疾病的人群，莫德纳专注于靶向mRNA疗法，提供了变革性的希望，开辟了可能改变生活的治疗途径。'
- en: '**Creating a global mRNA therapy delivery network**: Moderna’s potential creation
    of a global delivery network ensures that groundbreaking mRNA therapies reach
    even the most remote regions. This initiative bridges gaps and delivers hope on
    an international scale.'
  id: totrans-190
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**创建全球mRNA疗法输送网络**：莫德纳潜在的全球输送网络的创建，确保突破性的mRNA疗法能够覆盖到最偏远的地区。这项举措弥合了差距，带来了国际范围的希望。'
- en: Moderna’s consideration of outsourcing the production of mRNA therapeutics and
    vaccines to **contract manufacturing organizations** (**CMOs**) represents a significant
    strategic shift. Focusing on its core strengths, such as innovation and drug discovery,
    and partnering with specialized CMOs could offer numerous benefits, including
    cost savings, scalability, and agility. While this approach brings potential risks,
    a well-crafted strategy emphasizing quality assurance, ethical considerations,
    and alignment with Moderna’s overall goals could usher in a new era of pharmaceutical
    development.
  id: totrans-191
  prefs: []
  type: TYPE_NORMAL
  zh: 莫德纳考虑将mRNA疗法和疫苗的生产外包给**合同生产组织**（**CMO**）代表了一项重大的战略转变。专注于其核心优势，如创新和药物发现，并与专业的CMO合作，可以带来许多好处，包括节省成本、可扩展性和灵活性。虽然这种方法存在潜在风险，但通过强调质量保证、道德考量，并与莫德纳的整体目标保持一致的精心设计策略，可能会迎来制药开发的新时代。
- en: Moderna’s strategic move toward outsourcing pharma manufacturing
  id: totrans-192
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 莫德纳战略性地将制药生产外包
- en: 'Explore Moderna’s daring strategy to outsource pharma manufacturing, a pivotal
    move with the potential to dramatically lower production costs and boost revenue
    – factors that could directly influence their stock price. This section offers
    a deep dive into how Moderna aims to blend innovation and scalability, ensuring
    that breakthrough drugs are not just created, but are also distributed cost-effectively
    and safely:'
  id: totrans-193
  prefs: []
  type: TYPE_NORMAL
  zh: 探索莫德纳大胆的外包制药生产策略，这是一个具有潜力的大动作，能够显著降低生产成本并增加收入——这些因素可能会直接影响其股票价格。本节深入探讨了莫德纳如何将创新与可扩展性相结合，确保突破性药物不仅被创造出来，而且能够以成本效益高且安全的方式分发：
- en: The rationale for outsourcing
  id: totrans-194
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 外包的理由
- en: 'Moderna’s potential to outsource drug manufacturing mirrors a broader trend
    in the pharmaceutical sector. Key benefits could include the following:'
  id: totrans-195
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 莫德纳外包药物生产的潜力反映了制药行业中的一个更广泛趋势。关键的好处可能包括以下几点：
- en: '**Focus on core strengths**: Concentrating on mRNA therapeutic and vaccine
    design, Moderna can entrust manufacturing to experts'
  id: totrans-196
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**聚焦核心优势**：专注于mRNA疗法和疫苗设计，莫德纳可以将生产任务委托给专家。'
- en: '**Scalability**: Partnering with established contract-manufacturing-organizations
    (CMOs) facilitates scalable production without heavy capital investment'
  id: totrans-197
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**可扩展性**：与已建立的合同生产组织（CMO）合作，能够在不进行大量资本投资的情况下实现生产的可扩展性。'
- en: '**Global reach**: This strategy can enhance distribution efficiency and alignment
    with regional regulations'
  id: totrans-198
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**全球覆盖**：这一策略可以提高分销效率，并与地区性法规保持一致。'
- en: Selecting the right partners
  id: totrans-199
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 选择合适的合作伙伴
- en: 'Success hinges on careful partner selection, focusing on the following aspects:'
  id: totrans-200
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 成功依赖于谨慎的合作伙伴选择，重点关注以下几个方面：
- en: '**Quality assurance**: Moderna’s commitment to quality demands rigorous agreements
    and oversight with CMOs'
  id: totrans-201
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**质量保证**：莫德纳对质量的承诺要求与CMO签订严格的协议并进行监督。'
- en: '**Technology compatibility**: Choosing CMOs with mRNA experience is vital'
  id: totrans-202
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**技术兼容性**：选择具有mRNA经验的CMO至关重要。'
- en: '**Ethical considerations**: Adherence to ethical labor and environmental standards
    reflects Moderna’s values'
  id: totrans-203
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**道德考量**：遵守道德劳工和环保标准体现了Moderna的价值观。'
- en: Implications and risks
  id: totrans-204
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 影响与风险。
- en: 'Outsourcing benefits must be balanced against risks:'
  id: totrans-205
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 外包的好处必须与风险相平衡：
- en: '**Cost savings**: Reduced manufacturing capital expenses can boost R&D funding'
  id: totrans-206
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**节约成本**：降低制造资本开支可以增加研发资金。'
- en: '**Agility in innovation**: A focus on drug discovery and FDA approval can enhance
    responsiveness'
  id: totrans-207
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**创新敏捷性**：专注于药物发现和FDA批准可以提高响应能力。'
- en: '**Potential risks**: Strategic risk management is essential to navigate potential
    supply chain disruptions or quality issues'
  id: totrans-208
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**潜在风险**：战略风险管理对于应对潜在的供应链中断或质量问题至关重要。'
- en: Aligning with Moderna’s overall strategy
  id: totrans-209
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 与Moderna的整体战略对齐。
- en: 'Outsourcing can be pivotal in the following areas:'
  id: totrans-210
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 外包可以在以下领域发挥关键作用：
- en: '**Accelerating drug pipelines**: Rapidly bringing innovative drugs to market'
  id: totrans-211
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**加速药物管线**：迅速将创新药物推向市场。'
- en: '**Global expansion**: Enhancing Moderna’s global footprint'
  id: totrans-212
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**全球扩展**：增强Moderna的全球影响力。'
- en: '**Strategic collaborations**: Driving innovation and growth in new areas'
  id: totrans-213
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**战略合作**：推动新领域的创新和增长。'
- en: Outsourcing could underscore Moderna’s role as an innovator in therapeutic development.
    By aligning with quality partners, ethical principles, and strategic business
    goals, the benefits could be vast. However, careful management is crucial to ensure
    this model supports Moderna’s mission and values. In redefining its manufacturing
    strategy, Moderna stands to emphasize its commitment to innovative therapy rather
    than traditional pharmaceutical production, potentially propelling the company
    to new heights.
  id: totrans-214
  prefs: []
  type: TYPE_NORMAL
  zh: 外包可能会突显Moderna作为治疗开发创新者的角色。通过与优质合作伙伴、道德原则和战略商业目标对齐，所带来的好处可能巨大。然而，谨慎管理至关重要，以确保这一模式支持Moderna的使命和价值观。在重新定义其制造战略时，Moderna有望强调其对创新疗法的承诺，而非传统制药生产，这可能推动公司达到新的高度。
- en: In an era where technology and biology converge to shape the future of medicine,
    investment strategies must evolve to keep pace with this dynamic landscape. Enter
    Moderna Momentum – a groundbreaking investment philosophy designed for the biotech
    sphere, where science, finance, and innovation intertwine. It’s more than just
    a method; it’s a harmonious approach tailored to the unique rhythm of the biotech
    sector. In the following section, we will dive into the key components that make
    Moderna Momentum a visionary pathway for investors seeking to navigate the complex
    world of Moderna’s stock.
  id: totrans-215
  prefs: []
  type: TYPE_NORMAL
  zh: 在技术与生物学交汇、塑造医学未来的时代，投资策略必须与这一动态环境同步发展。迎接Moderna Momentum——这一为生物技术领域量身定制的革命性投资理念，科学、金融和创新交织在一起。它不仅仅是一种方法，而是一种和谐的策略，符合生物技术行业的独特节奏。在接下来的部分，我们将深入探讨Moderna
    Momentum的关键组成部分，展示其如何成为投资者导航Moderna股票复杂世界的远见之路。
- en: Moderna Momentum – a data-driven, sentiment-sensitive strategy for an mRNA masterstroke
  id: totrans-216
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: Moderna Momentum——一种数据驱动、情感敏感的mRNA杰作策略。
- en: Let’s review Moderna Momentum a groundbreaking investment strategy that brings
    together cutting-edge finance, data analytics, and biotechnology. In this section,
    you’ll master a strategy uniquely tailored to navigating the dynamic landscape
    of Moderna – a biotech juggernaut at the forefront of mRNA therapies. Uncover
    the intricacies of converting dense scientific milestones into smart investment
    moves, decode the secrets behind the company’s financial health using Power BI
    visualizations, and learn how to harness AI sentiment analysis tools such as ChatGPT
    for a truly holistic investment strategy.
  id: totrans-217
  prefs: []
  type: TYPE_NORMAL
  zh: 让我们回顾一下Moderna Momentum——这一开创性的投资策略将尖端金融、数据分析和生物技术结合在一起。在本部分，您将掌握一种独特的策略，帮助您应对Moderna——这家处于mRNA疗法前沿的生物技术巨头——的动态环境。揭示如何将复杂的科学里程碑转化为明智的投资举措，利用Power
    BI可视化解码公司财务健康状况，学习如何利用AI情感分析工具（如ChatGPT）制定全面的投资策略。
- en: Why is this a must-read? It’s a vibrant narrative that transcends traditional
    investing. This strategy resonates with anyone who sees Moderna not merely as
    a stock but as a focal point of scientific ingenuity and human aspiration. With
    this blueprint, you’ll be equipped to make investment decisions that are not only
    data-driven but also sentiment-sensitive, giving you the competitive edge, you
    need in today’s volatile biotech sector.
  id: totrans-218
  prefs: []
  type: TYPE_NORMAL
  zh: 为什么这是一本必读之作？它是一个超越传统投资的生动叙事。这一策略与那些不仅将 Moderna 看作一只股票，而是将其视为科学创新和人类抱负的核心的人产生共鸣。有了这一蓝图，你将能够做出不仅仅是数据驱动的，还能敏锐把握市场情绪的投资决策，为你在当今波动不定的生物技术行业中提供所需的竞争优势。
- en: '**Why choose Moderna Momentum?** Moderna Momentum represents a novel investment
    strategy. It orchestrates a blend of quantitative rigor and qualitative insights,
    attuned to the specific cadence of the biotech sector. This multifaceted approach
    embodies the intricate nature of biotech investing:'
  id: totrans-219
  prefs: []
  type: TYPE_NORMAL
  zh: '**为什么选择 Moderna Momentum？** Moderna Momentum 代表了一种创新的投资策略。它将定量的严谨性和定性的洞察力相结合，适应生物技术行业的特定节奏。这一多维方法体现了生物技术投资的复杂性：'
- en: '**Translating science**: It interprets complex scientific milestones, converting
    them into calculated investment decisions'
  id: totrans-220
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**解读科学**：它解读复杂的科学里程碑，将其转化为经过计算的投资决策。'
- en: '**Deciphering finance**: It unravels earnings and expenditure, portraying an
    accurate snapshot of Moderna’s fiscal well-being'
  id: totrans-221
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**解读财务**：它解开了收益和支出的谜团，呈现了 Moderna 财务状况的准确快照。'
- en: '**Harnessing innovation**: Utilizing AI-driven sentiment analysis, it offers
    a state-of-the-art tool to measure the market’s pulse'
  id: totrans-222
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**利用创新**：借助人工智能驱动的情绪分析，它提供了一种先进的工具，用于测量市场的脉动。'
- en: '**Adopting a holistic perspective**: Moderna is seen not merely as a stock
    but as a vibrant narrative of science, creativity, and human endeavor'
  id: totrans-223
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**采纳整体视角**：Moderna 被视为不仅仅是一只股票，而是科学、创造力和人类努力的生动叙事。'
- en: The Moderna Momentum strategy is intended for the discerning investor, unafraid
    to explore the multifarious terrain of biotech. It resonates with those who perceive
    beyond mere figures, recognizing the promise, potential, and vibrancy of a company
    poised to transform modern medicine.
  id: totrans-224
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna Momentum 策略面向具有洞察力的投资者，他们不畏探索生物技术领域的多样性。这一策略与那些不仅仅看重数字、而是能够识别有潜力、充满活力且有望改变现代医学的公司的人产生共鸣。
- en: 'This pioneering strategy combines both quantitative and qualitative metrics
    to craft an all-encompassing investment lens for Moderna’s stock, emphasizing
    the company’s role in the vital mRNA therapeutic and vaccine domain. Key aspects
    include the following:'
  id: totrans-225
  prefs: []
  type: TYPE_NORMAL
  zh: 这一开创性策略结合了定量和定性指标，打造了一种全面的 Moderna 股票投资视角，强调公司在关键的 mRNA 疗法和疫苗领域的作用。其核心要素包括以下内容：
- en: '**Analyzing financial indicators**: By dissecting essential signals such as
    clinical trial outcomes, regulatory verdicts, earnings reports, and R&D spending,
    it differentiates between buy and sell cues'
  id: totrans-226
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**分析财务指标**：通过剖析临床试验结果、监管裁定、财报和研发支出等关键信号，它区分买入和卖出信号。'
- en: '**Incorporating sentiment analysis**: Utilizing advanced AI such as GPT-4,
    it assesses market sentiment toward Moderna, translating positive or negative
    vibes into actionable buy or sell signals'
  id: totrans-227
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**融入情绪分析**：利用先进的人工智能，如 GPT-4，它评估市场对 Moderna 的情绪，并将积极或消极的情绪转化为可操作的买入或卖出信号。'
- en: By synthesizing these elements, Moderna Momentum offers an insightful method
    to traverse Moderna’s stock trajectory. Crafted to be anticipatory, adaptable,
    and attuned to both market fluctuations and internal dynamics, it equips investors
    with critical insights to refine their investment strategies.
  id: totrans-228
  prefs: []
  type: TYPE_NORMAL
  zh: 通过整合这些元素，Moderna Momentum 提供了一种深刻的方式来把握 Moderna 股票的走势。它旨在预测、适应并与市场波动和内部动态保持同步，帮助投资者获得关键洞察力，从而优化他们的投资策略。
- en: The uniqueness of the Moderna Momentum strategy lies in its integrated approach.
    Eschewing the traditional focus on financial parameters alone, it melds fiscal
    performance, regulatory variables, and sentiment analysis into a singular, actionable
    blueprint. This avant-garde strategy is tailored for those investors eager to
    harness contemporary tools to maintain a competitive edge in the ever-shifting
    investment terrain, particularly within the vibrant biotech sector.
  id: totrans-229
  prefs: []
  type: TYPE_NORMAL
  zh: Moderna Momentum 策略的独特性在于其整合性方法。摒弃传统仅专注于财务参数的做法，它将财务表现、监管变量和情绪分析融为一体，形成一套可操作的蓝图。这一前卫的策略专为那些渴望利用现代工具、在不断变化的投资环境中保持竞争优势的投资者量身定制，尤其是在充满活力的生物技术行业中。
- en: 'Here’s an in-depth look at the pillars of this strategy:'
  id: totrans-230
  prefs: []
  type: TYPE_NORMAL
  zh: 这是对该策略支柱的深入分析：
- en: '**Clinical trial results (standalone** **trade signal)**:'
  id: totrans-231
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**临床试验结果（独立的** **交易信号）**：'
- en: '**Buy**: Positive phase II/III results indicate scientific validation, a big
    step toward market access'
  id: totrans-232
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**买入**：积极的二期/三期结果表明科学验证取得进展，这是迈向市场准入的重大一步'
- en: '**Sell**: Failure in critical stages of trials spells potential doom for a
    product, and by extension, investment'
  id: totrans-233
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**卖出**：试验的关键阶段失败可能意味着产品前景黯淡，进而影响投资'
- en: '**FDA regulatory announcements (standalone** **trade signal)**:'
  id: totrans-234
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**FDA监管公告（独立的** **交易信号）**：'
- en: '**Buy**: Approvals mean market entry and revenue potential, a clear win for
    investors'
  id: totrans-235
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**买入**：批准意味着市场进入和收入潜力，是投资者的明确胜利'
- en: '**Sell**: Rejections or safety concerns signal roadblocks, often reflecting
    in stock price plummeting'
  id: totrans-236
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**卖出**：拒绝或安全性问题意味着障碍，通常会反映在股价的暴跌中'
- en: '**Earnings reports (combined with sentiment signal to** **implement trade)**:'
  id: totrans-237
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**盈利报告（与情绪信号结合以** **实施交易）**：'
- en: '**Buy**: Revenue growth outpacing expectations shows commercial strength, justifying
    optimism'
  id: totrans-238
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**买入**：收入增长超出预期，显示出商业实力，证明了乐观情绪的合理性'
- en: '**Sell**: Falling short is a warning sign of potential underlying issues'
  id: totrans-239
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**卖出**：未达预期是潜在问题的警示信号'
- en: '**R&D expenditure (combined with sentiment signal to** **implement trade)**:'
  id: totrans-240
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**研发支出（与情绪信号结合以** **实施交易）**：'
- en: '**Buy**: Consistent or slightly increasing R&D spend (>=10% YoY) reveals a
    healthy investment in future innovations, seeding tomorrow’s successes'
  id: totrans-241
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**买入**：持续或略有增加的研发支出（>=10%年增长）显示出对未来创新的健康投资，为明日的成功播下种子'
- en: '**Sell**: A sudden drastic increase (>20% YoY) might flag financial instability
    or desperation to innovate, posing risks to investors'
  id: totrans-242
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**卖出**：突如其来的大幅增长（>20%年增长）可能表明财务不稳定或迫切需要创新，给投资者带来风险'
- en: Why is R&D significant?
  id: totrans-243
  prefs: []
  type: TYPE_NORMAL
  zh: 为什么研发如此重要？
- en: R&D is the lifeblood of a biotech company. Too little spending can indicate
    a lack of innovation; too much can signify financial imprudence. A balanced growth
    in R&D reflects a company’s commitment to the future without losing sight of present
    stability.
  id: totrans-244
  prefs: []
  type: TYPE_NORMAL
  zh: 研发是生物技术公司命脉。投入太少可能表明缺乏创新；投入过多则可能意味着财务不审慎。研发的平衡增长反映了公司对未来的承诺，同时不会忽视当前的稳定性。
- en: '**Sentiment analysis (combined with either the earnings signal or R&D spend
    signal to** **implement trade)**:'
  id: totrans-245
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**情绪分析（与盈利信号或研发支出信号结合以** **实施交易）**：'
- en: '**Buy**: Persistent positive sentiment is a public vote of confidence, often
    translating into buying momentum'
  id: totrans-246
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**买入**：持续的积极情绪是公众信任的表现，通常会转化为买入势头'
- en: '**Sell**: Sustained negative sentiment can indicate underlying market skepticism
    or potential forthcoming downturns'
  id: totrans-247
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**卖出**：持续的负面情绪可能意味着市场怀疑情绪加剧或潜在的下行趋势'
- en: The role of AI
  id: totrans-248
  prefs: []
  type: TYPE_NORMAL
  zh: 人工智能的角色
- en: By leveraging AI tools such as GPT-4, sentiment analysis turns nebulous public
    opinion into tangible investment insights, capturing the mood of the market in
    real time.
  id: totrans-249
  prefs: []
  type: TYPE_NORMAL
  zh: 通过利用如GPT-4等AI工具，情绪分析能够将模糊的公众舆论转化为切实的投资洞察，实时捕捉市场情绪。
- en: '`Clinicaltrials.gov`'
  id: totrans-250
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '`Clinicaltrials.gov`'
- en: 'Now, we’ll take you on a hands-on journey in implementing the Moderna Momentum
    investment strategy, breaking down its multiple facets into easy-to-follow steps
    with help from ChatGPT as our guide. You’ll start by setting up your Python environment,
    obtain clinical trial data through APIs, and segueing into crafting trading signals
    based on FDA announcements and earnings reports. To enhance the strategy, we incorporate
    sentiment analysis using cutting-edge AI tools and refine the trade calls with
    real-time R&D spending data:'
  id: totrans-251
  prefs: []
  type: TYPE_NORMAL
  zh: 现在，我们将带您亲身体验实施Moderna Momentum投资策略的过程，逐步解析其多个方面，帮助您轻松掌握步骤，ChatGPT将作为我们的指南。您将从设置Python环境开始，通过API获取临床试验数据，并进而根据FDA公告和盈利报告制定交易信号。为了提升策略，我们结合使用最先进的AI工具进行情绪分析，并通过实时的研发支出数据完善交易决策：
- en: 'First, let’s install the required packages:'
  id: totrans-252
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 首先，让我们安装所需的软件包：
- en: '[PRE0]'
  id: totrans-253
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE0]'
- en: 'Run the following Python code:'
  id: totrans-254
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 运行以下Python代码：
- en: '[PRE1]'
  id: totrans-255
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE1]'
- en: 'Create a standalone buy or sell signal based on clinical trial news on the
    clinicaltrials.gov website:'
  id: totrans-256
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 基于临床试验新闻在`clinicaltrials.gov`网站上创建独立的买入或卖出信号：
- en: '**Buy signal**: Positive phase II/III results or successful completion of a
    trial, leading to potential regulatory review'
  id: totrans-257
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**买入信号**：积极的二期/三期结果或成功完成试验，可能导致监管审查'
- en: '**Sell signal**: Failure in phase II/III trials'
  id: totrans-258
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**卖出信号**：二期/三期试验失败'
- en: 'You will need to make sure that your CSV file includes data about the phase
    of the trial (for example, in a **Phase** column) and the outcome of the trial
    (for example, in an **Outcome** column):'
  id: totrans-259
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 你需要确保你的CSV文件包含关于试验阶段的数据（例如，在**Phase**列中）和试验结果的数据（例如，在**Outcome**列中）：
- en: '[PRE2]'
  id: totrans-260
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE2]'
- en: Important note
  id: totrans-261
  prefs: []
  type: TYPE_NORMAL
  zh: 重要说明
- en: This is a simplified example and may not be sufficient for actual trading. In
    practice, you would want to include additional checks and balances, such as checking
    whether you already hold shares before selling, and additional logic to determine
    the appropriate quantity and price for each order.
  id: totrans-262
  prefs: []
  type: TYPE_NORMAL
  zh: 这是一个简化的示例，可能不足以用于实际交易。实际上，你需要包括额外的检查和控制，例如在卖出之前检查是否已经持有股票，并且增加额外的逻辑来确定每个订单的适当数量和价格。
- en: 'FDA regulatory announcements (standalone trade signal):'
  id: totrans-263
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: FDA监管公告（独立的交易信号）：
- en: '**Buy**: Approval of a new drug/vaccine or a new indication for an existing
    drug'
  id: totrans-264
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**买入**：新药/疫苗的批准或现有药物的新适应症'
- en: '**Sell**: Regulatory rejection of a new drug/vaccine or a critical safety concern
    raised'
  id: totrans-265
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**卖出**：新药/疫苗的监管拒绝或提出的重大安全问题'
- en: '**Source**: FDA announcements'
  id: totrans-266
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**来源**：FDA公告'
- en: 'Here’s how you can use Python’s BeautifulSoup library to scrape the FDA’s press
    announcements web page for any articles that mention “Moderna.” Once we’ve done
    this, we can store the relevant data in a CSV file:'
  id: totrans-267
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 下面是如何使用Python的BeautifulSoup库来抓取FDA新闻公告网页中提到“Moderna”的文章。一旦我们完成这一步，我们就可以将相关数据存储到CSV文件中：
- en: '[PRE3]'
  id: totrans-268
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE3]'
- en: The script will run every day at 9:00 A.M. Please adjust the timing according
    to your needs. Note that this script should be running all the time to be able
    to execute the job. This script will search through all of the articles listed
    on the FDA’s press announcements page and find any that have “Moderna” in the
    title. It will then write the title, URL, and date of each article to a CSV file.
  id: totrans-269
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 该脚本将在每天上午9点运行。请根据你的需求调整时间。注意，这个脚本应该一直运行，以便能够执行任务。此脚本将搜索FDA新闻公告页面上列出的所有文章，并找到标题中包含“Moderna”的文章。然后，它将把每篇文章的标题、URL和日期写入CSV文件。
- en: Please note that this script only scrapes the first page of announcements. If
    you want to scrape more pages, you’ll have to modify the script to navigate to
    the next page and repeat the scraping process.
  id: totrans-270
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 请注意，这个脚本只会抓取公告的第一页。如果你想抓取更多页面，你需要修改脚本以导航到下一页并重复抓取过程。
- en: Important note on pagination
  id: totrans-271
  prefs: []
  type: TYPE_NORMAL
  zh: 关于分页的重要说明
- en: 'The current script fetches data only from the first page of results. If the
    data is spread across multiple pages, you’ll need to extend the script to handle
    pagination. Here are some general strategies to do so:'
  id: totrans-272
  prefs: []
  type: TYPE_NORMAL
  zh: 当前的脚本仅从结果的第一页抓取数据。如果数据分布在多个页面上，你需要扩展脚本以处理分页。以下是一些常见的策略：
- en: '`page`, `offset`, or `limit` in the API documentation. You can increment these
    parameters in a loop until you’ve fetched all pages:'
  id: totrans-273
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 在API文档中，`page`、`offset`或`limit`可以用来分页。你可以在循环中增加这些参数，直到抓取到所有页面：
- en: '[PRE4]'
  id: totrans-274
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE4]'
- en: '**Web scraping with the Next button**: If you’re scraping a website, identify
    the Next button’s HTML element and simulate a click, or navigate to the next URL,
    to scrape subsequent pages:'
  id: totrans-275
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**通过“下一页”按钮抓取网页**：如果你在抓取一个网站，识别“下一页”按钮的HTML元素并模拟点击，或者导航到下一个URL，以抓取后续页面：'
- en: '[PRE5]'
  id: totrans-276
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE5]'
- en: '**Rate limiting**: Always be aware of the rate-limiting policies when dealing
    with APIs or web scraping. Insert appropriate time delays in your loops to avoid
    getting blocked.'
  id: totrans-277
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**速率限制**：在处理API或网页抓取时，始终要注意速率限制政策。在循环中插入适当的时间延迟，以避免被封锁。'
- en: '**Data storage**: When dealing with multiple pages, consider storing the data
    incrementally – either appending it to a file or a database – to avoid losing
    all fetched data in case of an error or interruption.'
  id: totrans-278
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**数据存储**：处理多个页面时，考虑增量存储数据——将数据追加到文件或数据库中——以防止在出现错误或中断时丢失所有抓取的数据。'
- en: '**Create a standalone buy or sell signal based on FDA announcements on the**
    **FDA website**:'
  id: totrans-279
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**根据FDA公告在** **FDA网站**上创建独立的买入或卖出信号：'
- en: '**Buy**: Approval of a new drug/vaccine or a new indication for an existing
    drug'
  id: totrans-280
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**买入**：新药/疫苗的批准或现有药物的新适应症'
- en: '**Sell**: Regulatory rejection of a new drug/vaccine or a critical safety concern
    raised:'
  id: totrans-281
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**卖出**：新药/疫苗的监管拒绝或提出的重大安全问题：'
- en: '[PRE6]'
  id: totrans-282
  prefs:
  - PREF_IND
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE6]'
- en: '[PRE7]'
  id: totrans-283
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE7]'
- en: Again, you need to replace the `<ALPACA_API_KEY>` and `<ALPACA_SECRET_KEY>`
    placeholder variables with your actual API key and secret key from Alpaca. As
    before, keep in mind that this is a simplified example and may not be sufficient
    for actual trading. Be sure to implement the necessary checks and balances as
    per your trading strategy.
  id: totrans-284
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 同样，您需要将 `<ALPACA_API_KEY>` 和 `<ALPACA_SECRET_KEY>` 占位符变量替换为您从 Alpaca 获取的实际 API
    密钥和秘密密钥。如前所述，请记住，这是一个简化的示例，可能不足以进行实际交易。请确保根据您的交易策略实现必要的检查和控制。
- en: '`estimates` endpoint, which provides future and past earnings estimates. You
    could compare the actuals (which can be obtained from the `income` endpoint or
    the `earnings` endpoint) with the estimates to see if Moderna’s earnings were
    more than 10% above or below the estimate.'
  id: totrans-285
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '`estimates` 端点，提供未来和过去的收益预测。您可以将实际数据（可以通过 `income` 端点或 `earnings` 端点获得）与预测进行比较，查看
    Moderna 的收益是否超过或低于预测值 10% 以上。'
- en: 'Here is a Python code example of how you might do this with IEX Cloud. This
    version of the code uses the `csv` library to write the data to a file named `Moderna_earnings.csv`:'
  id: totrans-286
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 下面是一个使用 IEX Cloud 的 Python 代码示例。此代码版本使用 `csv` 库将数据写入名为 `Moderna_earnings.csv`
    的文件：
- en: '[PRE8]'
  id: totrans-287
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE8]'
- en: '`reportDate`, `totalRevenue`, and `researchAndDevelopment` fields from this
    endpoint.'
  id: totrans-288
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 来自此端点的 `reportDate`、`totalRevenue` 和 `researchAndDevelopment` 字段。
- en: 'Please replace `''YOUR_IEX_CLOUD_PUBLIC_KEY''` with your actual IEX Cloud public
    key in the following code snippet:'
  id: totrans-289
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 请将以下代码片段中的 `'YOUR_IEX_CLOUD_PUBLIC_KEY'` 替换为您的实际 IEX Cloud 公钥：
- en: '[PRE9]'
  id: totrans-290
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE9]'
- en: This script calculates the total R&D and total revenue for the past 12 months,
    then calculates R&D as a percentage of revenue. After, it writes this data to
    a CSV file and prints a buy or sell signal based on the value of R&D as a percentage
    of revenue. This job is scheduled to run every day at 9:00 A.M.
  id: totrans-291
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 该脚本计算过去 12 个月的总研发支出和总收入，然后计算研发占收入的百分比。接着，它将这些数据写入 CSV 文件，并根据研发占收入的百分比打印出买入或卖出信号。此任务安排每天上午
    9:00 执行。
- en: '**Sentiment analysis (combined with either the earnings signal or R&D spend
    signal to** **implement trade)**:'
  id: totrans-292
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '**情感分析（结合收益信号或研发支出信号进行交易）**：'
- en: '**Buy**: The positive sentiment score exceeds 0.2 (on a scale from -1 to 1)
    for a consistent period of a week'
  id: totrans-293
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**买入**：正向情感得分超过 0.2（在 -1 到 1 的范围内），并且持续一周以上'
- en: '**Sell**: The negative sentiment score dips below -0.2 for a week consistently'
  id: totrans-294
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**卖出**：负向情感得分持续一周低于 -0.2'
- en: '**Source**: News and social media sentiment analyzed using GPT-4 or similar
    sentiment analysis tools, which could be sourced from online news websites, Yahoo!
    Finance, and social media platforms such as X:'
  id: totrans-295
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**来源**：通过 GPT-4 或类似的情感分析工具分析的新闻和社交媒体情感，这些数据可能来源于在线新闻网站、Yahoo! Finance，以及社交媒体平台如
    X：'
- en: '[PRE10]'
  id: totrans-296
  prefs:
  - PREF_IND
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE10]'
- en: This script keeps track of the daily sentiment scores for the last 7 days and
    writes the weekly sentiment to a CSV file every day. It also generates a buy or
    sell signal if the weekly sentiment exceeds 0.2 or falls below -0.2, respectively.
  id: totrans-297
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 该脚本跟踪过去 7 天的每日情感得分，并将每周情感得分写入 CSV 文件。若每周情感得分超过 0.2 或低于 -0.2，则分别生成买入或卖出信号。
- en: Remember to replace `'YOUR_NEWSAPI_KEY'` with your actual News API key. As always,
    this is a simplified example and may not be sufficient for actual trading. You
    may need to adjust the sentiment thresholds and the decision-making logic to fit
    your specific use case. Also, note that the News API has certain limitations on
    the number of requests you can make, depending on your level of subscription.
  id: totrans-298
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 请记得将 `'YOUR_NEWSAPI_KEY'` 替换为您的实际 News API 密钥。和往常一样，这是一个简化的示例，可能不足以进行实际交易。您可能需要调整情感阈值和决策逻辑，以适应您的具体用例。另外，请注意，News
    API 对请求次数有一定限制，具体取决于您的订阅级别。
- en: '`Moderna_earnings.csv`'
  id: totrans-299
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '`Moderna_earnings.csv`'
- en: 'Sentiment score and trade signal: `sentiment_scores.csv`'
  id: totrans-300
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 情感得分和交易信号：`sentiment_scores.csv`
- en: To create a trading strategy based on multiple variables, you can combine the
    data from different CSV files, process them to generate trading signals, and submit
    trades accordingly using Alpaca’s API.
  id: totrans-301
  prefs: []
  type: TYPE_NORMAL
  zh: 要创建基于多个变量的交易策略，您可以将来自不同 CSV 文件的数据结合起来，处理这些数据以生成交易信号，然后使用 Alpaca 的 API 提交交易。
- en: 'The following script demonstrates how to achieve this using pandas. This script
    should be run after the two CSV files, `Moderna_earnings.csv` and `sentiment_scores.csv`,
    have been generated:'
  id: totrans-302
  prefs: []
  type: TYPE_NORMAL
  zh: 以下脚本演示了如何使用 pandas 实现此操作。该脚本应在生成 `Moderna_earnings.csv` 和 `sentiment_scores.csv`
    两个 CSV 文件之后运行：
- en: '[PRE11]'
  id: totrans-303
  prefs: []
  type: TYPE_PRE
  zh: '[PRE11]'
- en: '`Moderna_RD.csv`'
  id: totrans-304
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: '`Moderna_RD.csv`'
- en: 'Sentiment score and trade signal: `sentiment_scores.csv`:'
  id: totrans-305
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 情感得分和交易信号：`sentiment_scores.csv`：
- en: '[PRE12]'
  id: totrans-306
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE12]'
- en: Now, let’s look at a backtest example.
  id: totrans-307
  prefs: []
  type: TYPE_NORMAL
  zh: 现在，让我们看一个回测示例。
- en: To backtest the strategy you’ve described, you’ll need historical data for the
    period of June 30, 2022, through June 30, 2023, for all your variables – clinical
    trial data, FDA announcement data, earnings report data, sentiment analysis data,
    and R&D spend data.
  id: totrans-308
  prefs: []
  type: TYPE_NORMAL
  zh: 为了回测你描述的策略，你需要为2022年6月30日到2023年6月30日的这一时间段，准备所有变量的历史数据——临床试验数据、FDA公告数据、财报数据、情感分析数据和研发支出数据。
- en: 'Here’s a simplified example of how you might set up a backtest with Backtrader,
    assuming that you have a pandas DataFrame, `df`, containing historical price data
    for Moderna and the buy/sell signals generated from your combined variables:'
  id: totrans-309
  prefs: []
  type: TYPE_NORMAL
  zh: 这是一个简化的例子，展示了如何使用Backtrader设置回测，假设你已经有一个包含Moderna历史价格数据和通过组合变量生成的买卖信号的Pandas
    DataFrame `df`：
- en: '[PRE13]'
  id: totrans-310
  prefs: []
  type: TYPE_PRE
  zh: '[PRE13]'
- en: 'This Python code snippet uses the Backtrader library to perform a backtest
    on a trading strategy specifically for Moderna stock. Let’s break it down:'
  id: totrans-311
  prefs: []
  type: TYPE_NORMAL
  zh: 这段Python代码示例使用Backtrader库，对专门为Moderna股票设计的交易策略进行回测。让我们来拆解一下：
- en: Import the Backtrader library using `import backtrader` `as bt`.
  id: totrans-312
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 使用`import backtrader as bt`导入Backtrader库。
- en: This imports the Backtrader library for use in backtesting trading strategies.
  id: totrans-313
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 这导入了Backtrader库，用于回测交易策略。
- en: 'Define the trading strategy:'
  id: totrans-314
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 定义交易策略：
- en: '[PRE14]'
  id: totrans-315
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE14]'
- en: 'Let’s take a closer look at this code:'
  id: totrans-316
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 让我们更仔细地看一下这段代码：
- en: A custom trading strategy class, `ModernaStrategy`, is created, inheriting from
    `bt.Strategy`.
  id: totrans-317
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 创建了一个自定义的交易策略类`ModernaStrategy`，它继承自`bt.Strategy`。
- en: The `next()` method is implemented to specify the trading logic. Here, it checks
    for buy or sell signals in a Pandas DataFrame (`df`) and then executes trades
    accordingly.
  id: totrans-318
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '`next()`方法被实现，用来指定交易逻辑。这里，它会检查Pandas DataFrame（`df`）中的买入或卖出信号，然后根据这些信号执行交易。'
- en: 'Initialize the Backtrader engine:'
  id: totrans-319
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 初始化Backtrader引擎：
- en: '[PRE15]'
  id: totrans-320
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE15]'
- en: 'Let’s take a closer look:'
  id: totrans-321
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 让我们更仔细地看看：
- en: A Backtrader engine (`cerebro`) is created
  id: totrans-322
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 创建了一个Backtrader引擎（`cerebro`）
- en: The custom strategy is added to the engine
  id: totrans-323
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 自定义策略已添加到引擎中
- en: 'Add data and run the following:'
  id: totrans-324
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
  zh: 添加数据并运行以下代码：
- en: '[PRE16]'
  id: totrans-325
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE16]'
- en: 'Let’s explain this code:'
  id: totrans-326
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 让我们来解释一下这段代码：
- en: Data is fed into Backtrader using `bt.feeds.PandasData`, where `df` contains
    the historical price and signal data
  id: totrans-327
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 数据通过`bt.feeds.PandasData`导入Backtrader，其中`df`包含历史价格和信号数据
- en: Finally, `cerebro.run()` kicks off the backtesting process
  id: totrans-328
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 最后，`cerebro.run()`启动回测过程
- en: In this section, we guided you through building the Moderna Momentum investment
    strategy by combining traditional financial metrics with modern data science techniques.
    We set up your Python environment and progressed by pulling data from various
    sources to craft multi-dimensional trading signals. Finally, we wrapped things
    up with a backtest, giving you a comprehensive toolkit for biotech investing.
  id: totrans-329
  prefs: []
  type: TYPE_NORMAL
  zh: 在这一部分，我们引导你构建了Moderna Momentum投资策略，结合了传统的金融指标和现代数据科学技术。我们设置了你的Python环境，并通过从各种数据源提取数据，构建了多维度的交易信号。最后，我们通过回测为你提供了一个全面的生物技术投资工具包。
- en: In the next section, we’ll visualize all the data signals from the Moderna Momentum
    investment trade, Here, we’ll take you on a fascinating journey through designing
    an all-inclusive Power BI dashboard that captures the essence of all the data
    in one place. You’ll learn how to visually represent critical metrics such as
    clinical trial results, FDA announcements, earnings reports, and even sentiment
    analysis. We’ll supercharge our dashboard with ChatGPT-generated insights and
    Power BI’s predictive analytics, giving you a futuristic toolkit to decode stock
    market trends.
  id: totrans-330
  prefs: []
  type: TYPE_NORMAL
  zh: 在下一部分，我们将可视化所有Moderna Momentum投资交易的数据信号。在这里，我们将带你走进一个迷人的旅程，设计一个全方位的Power BI仪表盘，将所有数据的精髓集中在一个地方。你将学会如何直观地展示关键指标，如临床试验结果、FDA公告、财报，甚至是情感分析。我们将用ChatGPT生成的洞察和Power
    BI的预测分析来强力提升我们的仪表盘，给你一个未来感十足的工具包，用来解读股市趋势。
- en: The future of biotech trading – the Moderna Momentum trade visualization
  id: totrans-331
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 生物技术交易的未来——Moderna Momentum交易可视化
- en: 'As a Power BI expert, let’s break down each component of the Moderna Momentum
    trading strategy and the visualization that could be ideal for each:'
  id: totrans-332
  prefs: []
  type: TYPE_NORMAL
  zh: 作为一名Power BI专家，让我们逐一拆解Moderna Momentum交易策略的每个组件，以及每个组件可能适用的理想可视化方式：
- en: '**Clinical trial results**: A time series line graph would provide a visual
    representation of the clinical trial stages (phases I, II, and III) over time.
    This line could be color-coded to indicate successful trials (green), ongoing
    trials (yellow), and failed trials (red). Each data point (that is, trial) could
    be interactive, offering additional details on hover, such as the trial’s start
    and end dates, its goals, and its outcomes.'
  id: totrans-333
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**FDA regulatory announcements**: A similar time series line graph could be
    used to represent FDA regulatory announcements, with color-coding to differentiate
    between approvals (green) and rejections (red). A separate bar graph can visualize
    the number of approvals and rejections over time. Interactive features could provide
    further details about each announcement.'
  id: totrans-334
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Earnings reports**: A combination of a line graph and a bar graph would be
    ideal to visualize earnings data. The line graph could represent quarterly revenue
    over time, with markers to highlight instances where revenue growth surpasses
    or falls short of estimates. A bar graph could provide a year-over-year comparison
    of the estimated and actual revenues.'
  id: totrans-335
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**R&D expenditure**: A line graph could be used to represent R&D spending over
    time. The line could change color or become bold when the YoY increase exceeds
    20%. A separate area graph could show the R&D spending as a percentage of the
    total revenue, indicating how much of the revenue is reinvested in R&D.'
  id: totrans-336
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Sentiment analysis**: A sentiment score could be represented using a heat
    map, where each day (or week) is a cell, and its color represents the sentiment
    score (green for positive, red for negative, white for neutral). This will give
    a quick, at-a-glance understanding of the sentiment trend over time. A line graph
    could also be useful for showing sentiment scores over time, with the area above
    0.2 filled in green and below -0.2 filled in red.'
  id: totrans-337
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Historical stock price**: A time series line graph showing the historical
    stock price would be the main graph on the dashboard. This would give a quick
    overview of the company’s financial performance.'
  id: totrans-338
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Overlay data**: Overlay the stock price line graph with the other metrics
    from our previous examples. The aim is to provide an at-a-glance correlation between
    the stock price and the key factors affecting it:'
  id: totrans-339
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Clinical trial results**: Significant events such as the success/failure
    of major trials could be marked on the stock price graph with special symbols
    (such as upward or downward arrows).'
  id: totrans-340
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**FDA regulatory announcements**: Approval/rejection could also be marked on
    the stock price graph with appropriate symbols.'
  id: totrans-341
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Earnings reports and R&D expenditure**: Shaded areas or marker lines on the
    stock price graph could represent the periods of earnings report releases or changes
    in R&D spending.'
  id: totrans-342
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Sentiment analysis**: Underneath the stock price graph, a sentiment score
    graph could be synchronized to reflect the same timeline. This could help visually
    correlate major changes in sentiment with stock price fluctuations.'
  id: totrans-343
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Predictive analysis**: Power BI has built-in forecasting capabilities that
    could be leveraged to project future stock prices. An area of the graph showing
    the historical stock price could transition into a forecast area. This forecasted
    area could have confidence intervals that indicate the level of certainty in the
    predictions. Keep in mind that it’s critical to communicate to users that these
    are projections based on past trends and they should be used with caution.'
  id: totrans-344
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**ChatGPT insights**: When a user selects a data point in the prediction area,
    ChatGPT could generate potential scenarios explaining what might cause an increase
    or decrease. This can be based on the patterns observed in the historical data
    – for instance, “If Moderna announces successful clinical trial results, the stock
    price could potentially follow the trend observed in previous similar situations.”'
  id: totrans-345
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Load the CSV data into** **Power BI**:'
  id: totrans-346
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Open Power BI Desktop.
  id: totrans-347
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Click on **Home** in the top menu, then click on **Get Data** in the ribbon.
  id: totrans-348
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: In the dropdown, select **Text/CSV**.
  id: totrans-349
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Navigate to the location of your CSV files and select one. Click **Load** to
    import the data into Power BI.
  id: totrans-350
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Repeat steps II to IV for each CSV file.
  id: totrans-351
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Visualize the clinical** **trial results**:'
  id: totrans-352
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: In the Fields pane on the right, expand **clinical_trials_data**.
  id: totrans-353
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Drag the **date** field into the **Axis** area, **phase** into **Legend**, and
    **result** into **Values** of a new **Line chart**.
  id: totrans-354
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Customize the line colors in the **Format** pane to indicate successful trials
    (green), ongoing trials (yellow), and failed trials (red).
  id: totrans-355
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Visualize the FDA** **regulatory announcements**:'
  id: totrans-356
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: In the **Fields** pane on the right, expand **fda_announcements**.
  id: totrans-357
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Drag the **date** field into the **Axis** area and **announcement** into **Values**
    of a new **Line chart**.
  id: totrans-358
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Customize the line colors in the **Format** pane to differentiate between approvals
    (green) and rejections (red).
  id: totrans-359
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Visualize the** **earnings reports**:'
  id: totrans-360
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: In the **Fields** pane on the right, expand **Moderna_earnings**.
  id: totrans-361
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Drag the **date** field into the **Axis** area, **revenue** into **Values**,
    and **estimate** into **Tooltip** of a new **Line and Clustered** **Column** chart.
  id: totrans-362
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Visualize** **R&D expenditure**:'
  id: totrans-363
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: In the **Fields** pane on the right, expand **Moderna_RD**.
  id: totrans-364
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Drag the **date** field into the **Axis** area and **spend** into **Values**
    of a new **Line chart**.
  id: totrans-365
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Customize the line color or thickness in the **Format** pane when the YoY increase
    exceeds 20%.
  id: totrans-366
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Visualize** **sentiment analysis**:'
  id: totrans-367
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: In the **Fields** pane on the right, expand **sentiment_scores**.
  id: totrans-368
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Drag the **date** field into the **Axis** area and **score** into **Values**
    of a new **Line chart** or **Heat map**.
  id: totrans-369
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Customize the line or cell colors in the **Format** pane to represent the sentiment
    score (green for positive, red for negative, white for neutral).
  id: totrans-370
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Overlay data on the stock price line graph (save all historical stock prices
    for Moderna in a separate** **CSV file)**:'
  id: totrans-371
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Create a new **Line chart** with the **date** field in the **Axis** area and
    the **stock_price** field in the **Values** area.
  id: totrans-372
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Add special markers for significant events such as clinical trial results and
    FDA regulatory announcements.
  id: totrans-373
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Add shaded areas or marker lines for periods of earnings report releases or
    changes in R&D spending.
  id: totrans-374
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Synchronize a sentiment score graph underneath the stock price graph to reflect
    the same timeline.
  id: totrans-375
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Predictive analysis**:'
  id: totrans-376
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: On the stock price line graph, click on the **Analytics** pane.
  id: totrans-377
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Under **Forecast**, click **Add**. Adjust the forecast length and confidence
    interval as needed.
  id: totrans-378
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: '**ChatGPT insights**:'
  id: totrans-379
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Create a new **Card** visualization and bind it to a measure that calls a function
    to generate insights from ChatGPT.
  id: totrans-380
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Set up a drill-through or a click action on the prediction area of the stock
    price line graph to show the ChatGPT card.
  id: totrans-381
  prefs:
  - PREF_IND
  - PREF_OL
  type: TYPE_NORMAL
- en: Please note that while these steps provide a good start, you might need to adjust
    the configurations, such as filtering the data or changing the aggregation method,
    depending on your specific data and analysis needs.
  id: totrans-382
  prefs: []
  type: TYPE_NORMAL
- en: Let’s look at some additional suggestions to help you facilitate ChatGPT insights
    for a Power BI visualization.
  id: totrans-383
  prefs: []
  type: TYPE_NORMAL
- en: To get ChatGPT insights into a Power BI visualization, you’ll need to use Power
    BI’s ability to run Python scripts, along with a custom function that uses the
    GPT API to generate insights based on your data. We’ve provided a step-by-step
    guide to help you achieve this next.
  id: totrans-384
  prefs: []
  type: TYPE_NORMAL
- en: Prerequisites
  id: totrans-385
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: Make sure you’ve installed Python on your computer.
  id: totrans-386
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: 'Install the `openai` Python package, which will be used to interact with the
    ChatGPT API. You can install it using pip:'
  id: totrans-387
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '[PRE17]'
  id: totrans-388
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE17]'
- en: Make sure you have an API key from OpenAI to access the GPT API.
  id: totrans-389
  prefs: []
  type: TYPE_NORMAL
- en: 'Follow these steps:'
  id: totrans-390
  prefs: []
  type: TYPE_NORMAL
- en: 'Add the Python script in Power BI:'
  id: totrans-391
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Open Power BI Desktop and go to the **Home** tab.
  id: totrans-392
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Click **Python script** in the **Data** section.
  id: totrans-393
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: 'In the Python script editor that pops up, paste the following code:'
  id: totrans-394
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '[PRE18]'
  id: totrans-395
  prefs:
  - PREF_IND
  type: TYPE_PRE
  zh: '[PRE18]'
- en: Click **OK** to run the script.
  id: totrans-396
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: 'Create a new card visualization:'
  id: totrans-397
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: After setting up the Python script, go to your Power BI canvas.
  id: totrans-398
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Click on **Card** under **Visualizations**.
  id: totrans-399
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: In the **Fields** pane, bind this card to a measure that will call your Python
    function to get the insights. You’ll probably need to create a new measure in
    DAX that can interact with the Python function.
  id: totrans-400
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Add more interactivity by setting up a drill-through or a click action on your
    existing visualizations, such as the prediction area of your stock price line
    graph.
  id: totrans-401
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Go to **Action** under **Visualizations** and enable **Drillthrough**, or set
    up a click action to trigger the ChatGPT insights card when clicked.
  id: totrans-402
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Arrange your visualizations on your canvas as desired.
  id: totrans-403
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Save your Power BI file.
  id: totrans-404
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: After setting this up, the ChatGPT insights should update based on the underlying
    data whenever you or a user interacts with the visualizations. You may need to
    refresh the data or the Python script to see the updated insights due to the limitations
    of Power BI’s Python integration.
  id: totrans-405
  prefs: []
  type: TYPE_NORMAL
- en: This kind of interactive, insightful, and visually appealing dashboard would
    not only make investment trade monitoring easier but also bring a better understanding
    of how different factors interplay to affect Moderna’s market performance. It’s
    the future of financial analysis, blending innovative AGI technology with human
    ingenuity for unprecedented insights.
  id: totrans-406
  prefs: []
  type: TYPE_NORMAL
- en: Next, prepare to step into the future of healthcare and regulatory oversight
    like never before! In the next section, we will introduce FoodandDrugAdminGPT,
    a revolutionary AI persona that’s set to transform the way we approach drug development
    and approval. With unparalleled analytical prowess and an innovative approach,
    this system is poised to redefine the boundaries of pharmaceutical research, bringing
    life-saving treatments to patients faster and more efficiently. Welcome to a new
    era where technology and healthcare converge to create possibilities that were
    once beyond our reach!
  id: totrans-407
  prefs: []
  type: TYPE_NORMAL
- en: Introducing the future of drug development and regulatory approval with FoodandDrugAdminGPT
    – an AI persona
  id: totrans-408
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: Step into the future with FoodandDrugAdminGPT, an AI persona that’s about to
    revolutionize drug development and regulatory approval! If you’re intrigued by
    ChatGPT, wait until you see how this specialized AI model leverages generative
    language capabilities to predict a drug’s chances of getting FDA approval. We’ll
    explore into how FoodandDrugAdminGPT can become a key tool for pharmaceutical
    portfolio management, giving you a predictive edge. For Power BI enthusiasts,
    we’ll explore how you can integrate the AI’s insights into interactive dashboards,
    aiding in real-time decision-making. If you’re keen on ChatGPT, passionate about
    investing, or a fan of Power BI visualizations, you won’t want to miss this section.
  id: totrans-409
  prefs: []
  type: TYPE_NORMAL
- en: FoodandDrugAdminGPT is an innovative AI persona designed to excel in the arena
    of drug development and regulatory approval. Acting as a smart model that can
    predict potential challenges and opportunities for new pharmaceuticals before
    reaching the FDA, it offers drug manufacturers the ability to assess their products’
    approval likelihood, recognize areas for improvement, and thereby accelerate the
    overall development and approval process.
  id: totrans-410
  prefs: []
  type: TYPE_NORMAL
- en: 'The following critical indicators have been evaluated by FoodandDrugAdminGPT:'
  id: totrans-411
  prefs: []
  type: TYPE_NORMAL
- en: '**Drug composition and mechanism of action**: Analyzing the drug’s function
    and chemical structure.'
  id: totrans-412
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Preclinical data**: Reviewing non-human trial results for safety and effectiveness.'
  id: totrans-413
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Clinical trial design**: Evaluating the integrity and ethical considerations
    of human trials.'
  id: totrans-414
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Statistical analysis plans**: Confirming the validity of the planned statistical
    approaches.'
  id: totrans-415
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Patient population**: Ensuring that the drug’s intended users are adequately
    represented in the trial.'
  id: totrans-416
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Adverse event monitoring**: Scrutinizing procedures to monitor side effects
    and risks.'
  id: totrans-417
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Drug manufacturing and quality control**: Verifying that production aligns
    with FDA standards.'
  id: totrans-418
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: 'Now, let’s look at the profile of FoodandDrugAdminGPT:'
  id: totrans-419
  prefs: []
  type: TYPE_NORMAL
- en: '**Background**: Created to mirror the evaluation expertise of the FDA, with
    a core focus on drug safety and effectiveness.'
  id: totrans-420
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Skills**:'
  id: totrans-421
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Pharmaceutical development, clinical trials, and regulatory process expertise
  id: totrans-422
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: The ability to analyze intricate scientific data and trial designs
  id: totrans-423
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: Skill in recognizing potential risks and regulatory obstacles
  id: totrans-424
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: The capacity to communicate complex evaluations in a user-friendly way
  id: totrans-425
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Motivations**: Aims to facilitate pharmaceutical companies in hastening drug
    development and approval, striving to simplify the regulatory process and expedite
    patient access to treatments.'
  id: totrans-426
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Approach**: Offers all-encompassing assessments of vital drug development
    aspects, contextualizing them within contemporary scientific understanding and
    regulatory norms.'
  id: totrans-427
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Personality**: Renowned for thoroughness, objectivity, and insight, translating
    intricate assessments into accessible language.'
  id: totrans-428
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: While FoodandDrugAdminGPT provides invaluable evaluations, it’s essential to
    note that the final decision-making resides with the drug manufacturers and the
    FDA. Its guidance is meant to supplement professional judgment and inform – not
    prescribe – strategic choices in drug development and regulation.
  id: totrans-429
  prefs: []
  type: TYPE_NORMAL
- en: FoodandDrugAdminGPT heralds a new era in drug development and regulation, embodying
    a revolutionary system that leverages Generative AI. This AI persona builds upon
    the ChatGPT framework to present the next evolution in AI assistance across diverse
    aspects of food and drug administration. It encapsulates a forward-thinking approach
    that anticipates the future landscape of regulatory oversight, offering a new
    tool in the continuous quest for innovation in healthcare.
  id: totrans-430
  prefs: []
  type: TYPE_NORMAL
- en: We’ve just embarked on a thrilling journey through the world of FoodandDrugAdminGPT,
    a specialized AI persona that’s a game-changer in drug development and regulatory
    approval. We’ve seen how it’s not just for medical professionals; investors and
    data analysts can leverage its predictive power to make smarter choices and create
    compelling dashboards. It’s the thrilling intersection of AI’s future with finance
    and data visualization. If you’re someone who’s ever been fascinated by ChatGPT,
    intrigued by the stock market, or enthralled with the possibilities of Power BI,
    this is a pivotal moment where all these worlds collide.
  id: totrans-431
  prefs: []
  type: TYPE_NORMAL
- en: In the upcoming section, we’re diving into the futuristic capabilities of Microsoft
    JARVIS (HuggingGPT), an AI system that highlights collaborative intelligence and
    multifaceted excellence using Generative AI. You’re about to learn how this cutting-edge
    technology not only achieves complex tasks but also empowers investors with predictive
    insights and analysts with dynamic Power BI visualizations. So, why is this worth
    your time? Because we’re on the brink of an AI revolution that’s reshaping industries.
    Whether you’re a ChatGPT enthusiast, a savvy investor, or a Power BI expert, this
    is where your skills converge to unlock unprecedented opportunities.
  id: totrans-432
  prefs: []
  type: TYPE_NORMAL
- en: Unleashing collaborative intelligence – Microsoft Jarvis (GitHub)
  id: totrans-433
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: Meet Microsoft JARVIS, an advanced AI system that’s taking collaboration to
    new heights. Hosted on Hugging Face as HuggingGPT, JARVIS connects to as many
    as 20 AI models, including various open source **large language models** (**LLMs**)
    for images, videos, audio, and more. With ChatGPT at the helm, JARVIS seamlessly
    integrates these models to achieve complex tasks, and anyone can explore its capabilities
    right now.
  id: totrans-434
  prefs: []
  type: TYPE_NORMAL
- en: 'This dynamic system operates through four distinct stages:'
  id: totrans-435
  prefs: []
  type: TYPE_NORMAL
- en: '**Task planning**: ChatGPT analyzes user requests to understand their intention,
    breaking them down into manageable tasks.'
  id: totrans-436
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Model selection**: Then, it selects the most suitable expert models, curated
    by the FDA, for each task, including AI specialists in image analysis, drug interaction
    checking, and more.'
  id: totrans-437
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Task execution**: These expert models execute their tasks, feeding the results
    back to ChatGPT.'
  id: totrans-438
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: '**Response generation**: ChatGPT synthesizes the predictions and communicates
    the cohesive response back to the user.'
  id: totrans-439
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Known as FoodandDrugAdminGPT, this integrated system offers a versatile network
    of capabilities. It’s not confined to handling single modality inputs but can
    process various modalities and solve an array of complex AI tasks. Through corresponding
    model descriptions, FoodandDrugAdminGPT connects and integrates individual expert
    models, acting as the central brain that answers user queries with precision.
    Welcome to a new era of interconnected intelligence, where the whole is indeed
    greater than the sum of its parts.
  id: totrans-440
  prefs: []
  type: TYPE_NORMAL
- en: A new epoch in AI – the multifaceted excellence of HuggingGPT and its integration
    with Gradio models
  id: totrans-441
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: In the rapidly evolving landscape of AI, HuggingGPT has emerged as a luminary
    by leveraging the capabilities of LLMs. With integrations spanning hundreds of
    Hugging Face models, HuggingGPT is a versatile tool that shines across 24 diverse
    tasks such as text classification, image generation, object detection, question
    answering, and even text-to-video conversion. Its proficiency in handling multimodal
    information makes it a standout solution for intricate AI challenges.
  id: totrans-442
  prefs: []
  type: TYPE_NORMAL
- en: Nevertheless, like any groundbreaking technology, HuggingGPT is not without
    its challenges. Its performance may sometimes be hindered by efficiency and latency
    issues tied to frequent interactions with LLMs, constraints due to a maximum token
    limit that affects context length, and occasional instability resulting from non-adherence
    to instructions by the LLM.
  id: totrans-443
  prefs: []
  type: TYPE_NORMAL
- en: 'Yet, these limitations are overshadowed by HuggingGPT’s myriad advantages:'
  id: totrans-444
  prefs: []
  type: TYPE_NORMAL
- en: '**State-of-the-art performance**: By setting new benchmarks in numerous NLP
    tasks, it provides an optimal solution for AI challenges demanding sophisticated
    NLP capabilities. Customized fine-tuning can even yield results that equal or
    outpace the industry’s best models.'
  id: totrans-445
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Economical data requirements**: Thanks to pre-training on extensive text
    data, HuggingGPT slashes the need for labeled training data, thus cutting both
    time and expenses.'
  id: totrans-446
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Customizability and versatility**: From legal and medical to summarization
    tasks, HuggingGPT’s adaptability allows for tailoring models to specific domains,
    encompassing a wide array of applications such as chatbots, language translation,
    and text summarization.'
  id: totrans-447
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Interpretability**: Especially valuable in high-stakes domains such as legal
    or medical NLP, HuggingGPT’s interpretability facilitates a clear understanding
    of the model’s decision-making process, aiding in debugging and optimization.'
  id: totrans-448
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Open source accessibility**: Constructed on open source technologies, HuggingGPT
    is within reach of a vast community of developers and researchers, with no associated
    licensing fees or costs.'
  id: totrans-449
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Integration and scalability**: Its seamless compatibility with various tools
    and platforms, along with deployability at scale via cloud computing services,
    offers real-time processing for large volumes of text data.'
  id: totrans-450
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Despite some constraints, HuggingGPT continues to awe the AI community with
    its innovative performance, adaptability, transparency, and scalability. Its contributions
    affirm its standing as a formidable force within the field of AI.
  id: totrans-451
  prefs: []
  type: TYPE_NORMAL
- en: Unleashing creativity with Gradio – a gateway to simplified demos and GUIs for
    Hugging Face models
  id: totrans-452
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: 'Gradio, a revolutionary library in the machine learning ecosystem, empowers
    developers to effortlessly craft demos and GUIs for machine learning models. Its
    simplicity is akin to sharing a document link in Google Docs. With the advent
    of Gradio 2.0, integrating virtually any Hugging Face model with a GUI can be
    accomplished with just a single line of code. Let’s explore the compelling advantages
    of synergizing Gradio with Hugging Face models:'
  id: totrans-453
  prefs: []
  type: TYPE_NORMAL
- en: '`from_pipeline()` function. Moreover, you can efficiently construct a demo
    around the Inference API without having to load the model thanks to the `gr.load()`
    function.'
  id: totrans-454
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Hosting solutions**: Gradio demos can be hosted on Hugging Face Spaces, either
    through the GUI or entirely within Python. Additionally, Gradio demos residing
    on Hugging Face Spaces can be seamlessly embedded into your website.'
  id: totrans-455
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Flexibility unleashed**: Gradio’s design facilitates the parallel loading
    of multiple models or sequential alignment'
  id: totrans-456
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Choosing the right AI model – HuggingGPT (Jarvis) versus GPT-4 for domain-specific
    expertise
  id: totrans-457
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: The selection between HuggingGPT (Jarvis) and general LLMs such as GPT-4 comes
    down to their underlying design, purpose, and task-handling abilities. These distinctions
    can significantly impact their effectiveness in various applications.
  id: totrans-458
  prefs: []
  type: TYPE_NORMAL
- en: HuggingGPT (Jarvis) – the domain expert
  id: totrans-459
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
- en: HuggingGPT (Jarvis) stands out as an integrated system, uniquely tailored to
    work with several domain-specific models. Within specialized fields such as drug
    development, it houses expert models trained on tasks such as drug interactions,
    clinical trial design, FDA regulations, and more. When faced with a specific question,
    HuggingGPT (Jarvis) evaluates the query and summons the aptest expert model for
    a response. This specialization leads to insights that are both detailed and precisely
    aligned with the domain’s unique requirements.
  id: totrans-460
  prefs: []
  type: TYPE_NORMAL
- en: GPT-4 – the generalist
  id: totrans-461
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
- en: In contrast, GPT-4 operates as a singular, general LLM capable of managing a
    wide spectrum of tasks and inquiries without relying on external models. Its training
    on a diverse dataset empowers it to provide informative and imaginative answers
    across various subjects. While incredibly versatile, it lacks the acute, domain-specific
    acumen that HuggingGPT (Jarvis)’s expert models possess.
  id: totrans-462
  prefs: []
  type: TYPE_NORMAL
- en: Making the right choice
  id: totrans-463
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
- en: '**For deep, domain-specific knowledge**: HuggingGPT (Jarvis) is the preferred
    choice for tasks requiring profound expertise in specialized areas. In contexts
    such as drug development, its ability to draw on specific knowledge in pharmacology,
    biochemistry, or FDA regulations makes it invaluable.'
  id: totrans-464
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**For broad understanding and creativity**: GPT-4 shines when the task requires
    comprehensive knowledge across multiple subjects or creativity. Its well-rounded
    training enables it to approach problems that traverse different domains with
    creativity and a generalized understanding.'
  id: totrans-465
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Why we chose HuggingGPT (Jarvis) for the FoodandDrugAdminGPT persona
  id: totrans-466
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
- en: In our upcoming example, the necessity for precise, domain-focused insights
    led us to choose HuggingGPT (Jarvis) for the FoodandDrugAdminGPT persona. This
    choice aligns with the complexity and specialized nature of the tasks at hand,
    where general knowledge or creativity alone would not suffice. Jarvis’s ability
    to leverage expert models specific to the field ensures a level of accuracy and
    depth that positions it as the optimal solution for this application.
  id: totrans-467
  prefs: []
  type: TYPE_NORMAL
- en: Harnessing specialized intelligence – FoodandDrugAdminGPT’s implementation using
    HuggingGPT for multimodal solutions in the regulatory landscape
  id: totrans-468
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: One standout feature of the FoodandDrugAdminGPT system is its strategic task
    planning. By dissecting user requests into solvable tasks and matching them to
    the appropriate expert models, it crafts a cohesive plan of action. This thoughtful
    analysis and allocation enable FoodandDrugAdminGPT to generate intelligent plans,
    employ external models, and seamlessly integrate multimodal perceptual capabilities
    to navigate complex AI challenges.
  id: totrans-469
  prefs: []
  type: TYPE_NORMAL
- en: 'The comprehensive contributions of the FoodandDrugAdminGPT system are as follows:'
  id: totrans-470
  prefs: []
  type: TYPE_NORMAL
- en: '**Bridging GAI with expertise**: The system unites LLMs with specialized expert
    models, presenting an innovative framework for generative-ai (GAI) solutions.
    Utilizing LLMs for planning and decision-making, FoodandDrugAdminGPT selectively
    deploys expert models for individual tasks.'
  id: totrans-471
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Providing multimodal and reliable services**: By harmonizing numerous task-specific
    models within the FDA network, FoodandDrugAdminGPT can adeptly manage AI tasks
    across various modalities and domains, elevating the system’s adaptability.'
  id: totrans-472
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Emphasizing the importance of task planning**: The vital role of planning
    within FoodandDrugAdminGPT is accentuated, with methodical evaluations designed
    to gauge the prowess of LLMs in devising effective strategies.'
  id: totrans-473
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Demonstrating versatility across modalities**: Comprehensive experiments
    in language, vision, speech, and cross-modality highlight the system’s proficiency
    in comprehending and resolving intricate tasks specific to the food and drug administration
    sector.'
  id: totrans-474
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: This innovative system offers an elegant solution to a wide array of AI challenges,
    transcending multiple modalities and domains. It heralds a future where AI’s capabilities
    can be harnessed to enhance efficiency and accuracy within the food and drug administration
    field, opening doors to potential applications in various other sectors. By weaving
    together the strengths of both generalized and specialized AI, FoodandDrugAdminGPT
    exemplifies an innovative approach that could redefine how we utilize AI.
  id: totrans-475
  prefs: []
  type: TYPE_NORMAL
- en: Here, you’ll discover the wizardry of blending Gradio’s revolutionary capabilities
    with Hugging Face’s machine learning models. We’ll guide you through key steps,
    starting from obtaining your OpenAPI API key to crafting your own Gradio demo
    using the `from_pipeline()` function. What makes this essential reading? By mastering
    these techniques, you’ll be armed with the know-how to effortlessly create, host,
    and embed advanced machine learning demos in a matter of minutes. So, prepare
    your development environment, because a simplified yet powerful world of machine
    learning demos awaits!
  id: totrans-476
  prefs: []
  type: TYPE_NORMAL
- en: HuggingGPT model and Gradio demo
  id: totrans-477
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: 'Follow these steps:'
  id: totrans-478
  prefs: []
  type: TYPE_NORMAL
- en: Obtain an OpenAPI API key if you don’t already have one.
  id: totrans-479
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Sign up for a free account at Hugging Face – huggingface.co.
  id: totrans-480
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Navigate to **Settings** > **Access Tokens** by clicking the links on the left
    rail of the Hugging Face website.
  id: totrans-481
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Click **New Token** on the Hugging Face website.
  id: totrans-482
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Name the token (anything at all), select **write** as the role, and click **Generate**
    in Hugging Face.
  id: totrans-483
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Copy the API key and keep it somewhere you can easily access it.
  id: totrans-484
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Navigate to https://huggingface.co/spaces/microsoft/HuggingGPT.
  id: totrans-485
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Paste your OpenAPI key and Hugging Face token into the appropriate fields. Then,
    click the **Submit** button next to each.
  id: totrans-486
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: Enter your prompt at the bottom of the query box and click **Send**.
  id: totrans-487
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: In the next section, we’ve designed a multi-section roadmap aimed at equipping
    you with a formidable understanding of biotech investment, particularly in the
    landscape of drug development and regulatory approval. Let’s break down why each
    section is crucial, what you will learn, and how it will impact your investment
    decisions.
  id: totrans-488
  prefs: []
  type: TYPE_NORMAL
- en: Section 1 – investment insight with FoodandDrugAdminGPT – a comprehensive query
    guide
  id: totrans-489
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: The first section serves as an introductory platform for both seasoned Wall
    Street analysts and individual investors keen on the biotech sector. We’ll deconstruct
    the complex maze of drug approvals and market strategies by introducing targeted
    questions that can offer a panoramic view of the drug development life cycle.
    The questions in this section will help you discern key elements, such as market
    approval timelines, potential market size, competitive landscapes, and regulatory
    risks. The guidance from FoodandDrugAdminGPT acts as a supplemental tool to your
    professional acumen, filling gaps in your knowledge and pointing you in the direction
    of wise investment choices.
  id: totrans-490
  prefs: []
  type: TYPE_NORMAL
- en: Why it matters
  id: totrans-491
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: The understanding gleaned from these queries will not only shed light on the
    approval process but also align your investment focus on factors that genuinely
    impact a drug’s commercial viability. It’s akin to arming yourself with a precise
    compass in a territory laden with both opportunities and pitfalls.
  id: totrans-492
  prefs: []
  type: TYPE_NORMAL
- en: Section 2 – Moderna’s drug pipeline – tailored insight for investment and Wall
    Street analysis
  id: totrans-493
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: In this section, we will focus on providing an investment-oriented breakdown
    of Moderna’s existing products and those in the pipeline. Questions will be honed
    to give you insights into critical issues such as Emergency Use Authorizations,
    Clinical Trials for various vaccines, and regulatory milestones. Utilizing AI
    tools such as HuggingGPT, we will specialize these questions to adhere to the
    most recent FDA guidelines and market information.
  id: totrans-494
  prefs: []
  type: TYPE_NORMAL
- en: Why it matters
  id: totrans-495
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: Understanding Moderna’s existing portfolio allows you to make well-informed
    decisions about short-term investment opportunities. By knowing where each drug
    stands in terms of approval and market readiness, you’ll be better equipped to
    gauge immediate returns and risk factors.
  id: totrans-496
  prefs: []
  type: TYPE_NORMAL
- en: Section 3 – Unlocking Moderna’s pipeline – critical questions for investors
    using HuggingfaceGPT
  id: totrans-497
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: '*Section 3* picks up where *Section 2* leaves off, but goes a level deeper.
    Here, we will focus on specific drugs that are still in the development or clinical
    trial stage. This part employs more complex, targeted queries using AI tools,
    enabling you to assess long-term prospects concerning Moderna’s pipeline. Questions
    will delve into the timelines of drug rollouts, competitive landscapes for vaccines,
    and Moderna’s strategic partnerships and funding.'
  id: totrans-498
  prefs: []
  type: TYPE_NORMAL
- en: Why it matters
  id: totrans-499
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: If you’re looking at a long-term investment strategy, understanding the future
    potential of a company’s pipeline is crucial. This section will allow you to dig
    deeper into drugs that could become major market players in the future, thereby
    helping you understand the long-term growth trajectory and the associated risks.
  id: totrans-500
  prefs: []
  type: TYPE_NORMAL
- en: Overall implications
  id: totrans-501
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: The objective of our guide is to transform your general understanding of biotech
    investment into a specialized, multi-faceted skill set. By dividing your learning
    into these three distinct but complementary sections, we have provided a comprehensive
    toolkit for you to navigate the investment terrain in both the short term and
    long term. In essence, you’ll be empowered to make insightful decisions that capitalize
    on immediate opportunities while also preparing for future market shifts.
  id: totrans-502
  prefs: []
  type: TYPE_NORMAL
- en: Section 1 – investment insight with FoodandDrugAdminGPT – a comprehensive query
    guide
  id: totrans-503
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: 'Investors and Wall Street analysts may focus on areas such as market approval,
    post-approval changes, market potential, competition, and regulatory risks related
    to drug development. Here’s a streamlined set of questions:'
  id: totrans-504
  prefs: []
  type: TYPE_NORMAL
- en: '**Market approval timeline**: Considering the IND stage, what’s the expected
    timeline for our drug to reach the market?'
  id: totrans-505
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Potential market size**: What could be the potential market size for our
    pancreatic cancer drug candidate?'
  id: totrans-506
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Competitive landscape**: How can we analyze the competitive landscape for
    our pancreatic cancer drug?'
  id: totrans-507
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Regulatory risks**: What potential regulatory risks should we consider in
    drug development?'
  id: totrans-508
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Cost-benefit analysis**: How should we approach cost-benefit analysis to
    determine potential pricing?'
  id: totrans-509
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**International expansion**: What should we consider when planning for international
    markets?'
  id: totrans-510
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: These questions offer a holistic view of drug approval, focusing on investment
    aspects, while remembering that FoodandDrugAdminGPT guides and supplements professional
    expertise.
  id: totrans-511
  prefs: []
  type: TYPE_NORMAL
- en: Section 2 – Moderna’s drug pipeline – tailored insight for investment and Wall
    Street analysis
  id: totrans-512
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: 'HuggingGPT can help focus questions on Moderna’s drug pipeline specific to
    investors and Wall Street analysts. Here’s an example:'
  id: totrans-513
  prefs: []
  type: TYPE_NORMAL
- en: '**Emergency use authorization**: Has the FDA granted EUA for Moderna’s next-generation
    COVID-19 vaccine, mRNA-1283?'
  id: totrans-514
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Clinical trials for flu vaccines**: What are the phases of the flu vaccines
    mRNA-1010, mRNA-1020, mRNA-1030, mRNA-1011, and mRNA-1012 according to the FDA?'
  id: totrans-515
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Regulatory insights for the RSV vaccine**: Has the FDA made any announcements
    about the approval process for Moderna’s mRNA-1345?'
  id: totrans-516
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Section 3 – unlocking Moderna’s pipeline – critical questions for investors
    using HuggingfaceGPT
  id: totrans-517
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: 'Here’s a focused set of questions to delve into Moderna’s pipeline from an
    investor’s perspective:'
  id: totrans-518
  prefs: []
  type: TYPE_NORMAL
- en: '**COVID-19 vaccine timeline**: What’s the timeline for mRNA-1283’s commercial
    rollout? What regulatory obstacles might Moderna face?'
  id: totrans-519
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Flu vaccines landscape**: Can you comment on the competitive landscape for
    Moderna’s flu vaccines and differentiation strategies?'
  id: totrans-520
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Combination vaccines**: What’s the status of Moderna’s combination vaccines
    for COVID and flu (mRNA-1073 and mRNA-1083) in clinical trials?'
  id: totrans-521
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Financial partnership**: Can you detail the financial implications of Moderna’s
    50-50 global profit sharing with Merck for mRNA-4157?'
  id: totrans-522
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: 'Zika vaccine development: How has external funding from BARDA impacted the
    development of mRNA-1893, a Zika vaccine?'
  id: totrans-523
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: These tailored questions offer a comprehensive understanding of Moderna’s portfolio,
    considering the specific concerns of the investment community. By using tools
    such as HuggingGPT, questions can be further adapted to cater to specific FDA
    regulations or investment interests, enhancing the detailed analysis of Moderna’s
    assets.
  id: totrans-524
  prefs: []
  type: TYPE_NORMAL
- en: This next section shows how GPT-4 and future LLMs could potentially impact healthcare
    and biotech companies such as Moderna by helping them develop new drugs and treatments
    more quickly and accurately.
  id: totrans-525
  prefs: []
  type: TYPE_NORMAL
- en: Revolutionizing biotech with GPT-4 – Moderna’s pathway to accelerated drug discovery
  id: totrans-526
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: In the dynamic field of healthcare and biotech, companies such as Moderna are
    on the verge of an exciting era, marked by the integration of LLMs such as OpenAI’s
    GPT-4\. This shift has significant implications for drug discovery and development,
    promising to reshape the industry.
  id: totrans-527
  prefs: []
  type: TYPE_NORMAL
- en: '**Introducing GPT-4 in biotech**: GPT-4, created by OpenAI, is not just another
    language model. It has the potential to accelerate drug discovery by performing
    complex compositional and translation tasks. GPT-4 can analyze chemical structures,
    properties, and reactions, identifying compounds with similar attributes to known
    drugs. By modifying them to ensure they are not patented, it can significantly
    save time and resources.'
  id: totrans-528
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Moderna’s strategy with GPT-4**: Moderna is uniquely positioned to leverage
    GPT-4 in revolutionizing drug discovery. By focusing on the most promising compounds,
    GPT-4 can reduce both cost and time in the development process. An increasingly
    popular approach is “drug repurposing,” where GPT-4 can aid in redirecting existing
    drugs for new uses, thus cutting through the traditionally high costs and long
    timelines of new drug development.'
  id: totrans-529
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**The future with AGI**: The potential reach of AGI in drug development goes
    even further. It could allow researchers to pinpoint new targets for drugs and
    treatments more quickly and accurately. While concerns about AGI’s safety in drug
    development exist, OpenAI’s commitment to ensuring AGI’s alignment with human
    values, robust control, safety, transparency, fairness, and privacy anchors the
    mission.'
  id: totrans-530
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**A new horizon for healthcare**: The integration of LLMs such as GPT-4 heralds
    a transformation that could reshape the pharmaceutical landscape, making it more
    efficient and resourceful. For Moderna, and indeed for the biotech industry as
    a whole, embracing these advanced AI models could pave the way for unprecedented
    advancements, shaping a brighter and healthier future for all.'
  id: totrans-531
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: OpenAI’s pinnacle against tech giants
  id: totrans-532
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: 'A monumental question concludes this chapter: how did OpenAI, with merely 250
    people, outshine the colossal R&D teams of leading tech companies to create ChatGPT?
    The key to OpenAI’s success lies in the following aspects:'
  id: totrans-533
  prefs: []
  type: TYPE_NORMAL
- en: '**Mission-driven focus**: Dedicated to making AGI beneficial for humanity,
    OpenAI prioritized breakthrough projects such as ChatGPT'
  id: totrans-534
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Advanced research**: Continually pushing AGI’s boundaries and openly sharing
    discoveries'
  id: totrans-535
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Risk embracement**: Boldly accepting risks allowed for substantial progress'
  id: totrans-536
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Cooperative culture**: Aligning with global institutions to face AGI’s challenges'
  id: totrans-537
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Strategic talent acquisition**: Attracting top talents that made impactful
    strides'
  id: totrans-538
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: OpenAI’s triumph isn’t a mere tech sensation; it showcases AI’s transformative
    power across various sectors. As the AI landscape evolves, smaller innovators
    such as OpenAI can challenge the status quo, although tech giants, with their
    vast resources, remain formidable contenders.
  id: totrans-539
  prefs: []
  type: TYPE_NORMAL
- en: OpenAI and Moderna – a new frontier in drug discovery
  id: totrans-540
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: 'The collaborative potential between OpenAI and Moderna offers exciting prospects
    in pharmaceuticals:'
  id: totrans-541
  prefs: []
  type: TYPE_NORMAL
- en: 'RAD collaboration:'
  id: totrans-542
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: 'Data analysis and compound identification: Moderna can harness GPT-4 to analyze
    vast scientific data, identifying and modifying compounds'
  id: totrans-543
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: 'Repurposing existing drugs: GPT-4’s pattern recognition could help repurpose
    existing drugs for new uses'
  id: totrans-544
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: 'Collaborative Research: Tailored AI solutions could be developed in collaboration
    with OpenAI, leveraging Moderna’s mRNA expertise'
  id: totrans-545
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: 'Ethical alignment:'
  id: totrans-546
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: 'Safety and transparency: Both entities prioritize ethical practices, ensuring
    responsible development and rigorous testing'
  id: totrans-547
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: 'Fairness and privacy: OpenAI’s principles could guide Moderna’s clinical trials
    and patient data management'
  id: totrans-548
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: 'Future opportunities and global impact:'
  id: totrans-549
  prefs:
  - PREF_OL
  type: TYPE_NORMAL
- en: 'AGI in drug development: The advent of AGI might revolutionize Moderna’s processes,
    targeting drugs and optimizing trials with unparalleled precision'
  id: totrans-550
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: 'Broadening global reach: AI-driven insights could extend Moderna’s ability
    to address diverse health challenges globally'
  id: totrans-551
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
- en: OpenAI’s innovative technology, especially GPT-4, opens doors for Moderna. Integrating
    these AI technologies can accelerate research, align with ethical principles,
    and pave the way for collaboration and innovation. The potential synergy between
    Moderna and OpenAI is poised to redefine drug discovery, leading to global breakthroughs
    that could benefit humanity. As we transition into discussing the broader implications
    of AGI in the next section, this partnership stands as a testament to the boundless
    possibilities inherent in the ethical and innovative application of AI in healthcare.
  id: totrans-552
  prefs: []
  type: TYPE_NORMAL
- en: OpenAI’s history and focus on AGI
  id: totrans-553
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: OpenAI was established in December 2015 as a non-profit, aiming to ensure AGI
    benefits humanity. The founders, including Elon Musk, Sam Altman, and others,
    kick-started an organization that’s now at the forefront of AGI.
  id: totrans-554
  prefs: []
  type: TYPE_NORMAL
- en: 'Here’s a brief timeline of OpenAI:'
  id: totrans-555
  prefs: []
  type: TYPE_NORMAL
- en: '**2015**: OpenAI’s inception with the commitment to use any influence over
    AGI to avoid its harmful uses.'
  id: totrans-556
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**2016-2018**: OpenAI publishes high-impact research papers and develops AI
    technologies, emphasizing a cooperative approach.'
  id: totrans-557
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**2019**: A transition was made to a “capped-profit” model to attract more
    funding and compete with for-profit AI entities.'
  id: totrans-558
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**2020**: The launch of GPT-3, a language prediction model garnering significant
    attention.'
  id: totrans-559
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**2021**: The introduction of the GPT-3 API, enabling developers to utilize
    the model in various applications.'
  id: totrans-560
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**2022**: The DALL-E and CLIP neural networks were unveiled, and a free preview
    of ChatGPT was provided.'
  id: totrans-561
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**2023**: GPT-4 was released and ten $100,000 grants for building prototypes
    of a democratic process for steering AI were provided.'
  id: totrans-562
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**August 2023**:'
  id: totrans-563
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: The first acquisition was on August 16 via Global Illumination, based in New
    York. The company focused on open source technology for online game production.
    It was an acquire-to-hire purchase based on the company’s expertise in building
    creative tools and digital experiences.
  id: totrans-564
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: ChatGPT was released for enterprise on August 28\. It has enterprise-grade security
    and privacy, higher-speed access, longer context windows, and customization options.
  id: totrans-565
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**September 2023**:'
  id: totrans-566
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Dall-E 3 announcement on September 20, with it being released in October 2023
  id: totrans-567
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: ChatGPT voice enablement on mobile devices
  id: totrans-568
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: ChatGPT image recognition
  id: totrans-569
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: The next section provides an outline of OpenAI’s advancements in AGI and its
    alignment, followed by its potential future applications, particularly in the
    finance sector. This material emphasizes the critical importance of AGI and reinforces
    the connection to finance.
  id: totrans-570
  prefs: []
  type: TYPE_NORMAL
- en: OpenAI’s AGI initiatives – a trailblazing journey toward intelligence revolution
  id: totrans-571
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: OpenAI’s notable initiatives, such as the development of GPT models, are leading
    the AGI revolution. From GPT-3’s human-like text generation to exploring GPT-4’s
    potential trillion parameters, these language models are transforming the AI landscape.
  id: totrans-572
  prefs: []
  type: TYPE_NORMAL
- en: The focus on reinforcement learning, as seen in models such as Dactyl and OpenAI
    Five, is also groundbreaking. Fine-tuning processes such as human alignment and
    policy compliance through reinforcement learning ensure GPT-4’s performance aligns
    with human values.
  id: totrans-573
  prefs: []
  type: TYPE_NORMAL
- en: In collaborations, OpenAI is forging alliances with Microsoft and global research
    institutions, committing to a cooperative AGI community. Their goal? Ensuring
    AGI remains an ally, not a threat, to humanity.
  id: totrans-574
  prefs: []
  type: TYPE_NORMAL
- en: AGI – alignment and why it matters – conducting the symphony of intelligence
  id: totrans-575
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: Imagine a world where AGI reflects our spirit and our ethos, and amplifies our
    capabilities. The Alignment Team at OpenAI ensures that AGI, a marvel that can
    transcend human cognition, remains a faithful reflection of our objectives.
  id: totrans-576
  prefs: []
  type: TYPE_NORMAL
- en: Their responsibilities include scalable oversight, generalization, automated
    interpretability, robustness, and adversarial testing. Picture these as the guiding
    principles that keep AGI’s performance ethical, reliable, and resilient – even
    in the unpredictable world of finance.
  id: totrans-577
  prefs: []
  type: TYPE_NORMAL
- en: AGI principles and future scenarios in finance – your financial partner of tomorrow
  id: totrans-578
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: 'As AGI becomes a core pillar of our financial ecosystem, understanding the
    Alignment Team’s work ensures reliability and transparency in AGI’s financial
    applications. Here’s a glimpse into the thrilling territories AGI may conquer:'
  id: totrans-579
  prefs: []
  type: TYPE_NORMAL
- en: '**AGI-driven business intelligence**: Imagine AGI acting as an oracle, offering
    real-time insights, forecasting opportunities, and bottlenecks in businesses like
    never before'
  id: totrans-580
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**AGI-enhanced financial market predictions**: AGI could revolutionize financial
    analysis and trading, deciphering hidden patterns and crafting innovative trading
    strategies'
  id: totrans-581
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Revolutionized financial advisory**: AGI could provide ultra-personalized
    financial advice, considering an individual’s complete life landscape to offer
    truly bespoke recommendations'
  id: totrans-582
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Real-time risk management**: AGI might serve as a vigilant guardian, scanning
    data for potential risks and advising on timely interventions'
  id: totrans-583
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Democratization of financial services**: AGI could democratize high-quality
    financial services, fostering financial literacy and independence across the globe'
  id: totrans-584
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: However, as we sail into these exciting frontiers, the balance between AGI’s
    immense potential and ethical considerations such as job displacement, privacy,
    and fair access must remain at the forefront. Engaging in open dialogues will
    be pivotal in crafting an AGI-fueled future that is not just innovative but also
    inclusive and responsible.
  id: totrans-585
  prefs: []
  type: TYPE_NORMAL
- en: Summary
  id: totrans-586
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: This chapter has been an exhilarating odyssey through the multifaceted world
    of AI, finance, and biotechnology. We began with an exploration of GPT-4’s role
    in accelerating Moderna’s drug discovery. We ventured into the thrilling realm
    of momentum trading and the precision of Power BI visualizations. We also unveiled
    Moderna’s ambitious collaborations with IBM and Carnegie Mellon, their focus on
    combating cancer, future pandemics, and the innovative approach to outsourcing
    production. Next, we delved into the fascinating intersection of autonomous bots
    with Jarvis and HuggingGPT. We traced OpenAI’s journey toward AGI and the groundbreaking
    convergence of AI and quantum computing. Finally, we contemplated the ethical
    alignment of AGI, underscoring the importance of human values. This chapter has
    been a kaleidoscopic view of innovation, partnership, ambition, and ethical responsibility,
    setting the stage for what lies ahead.
  id: totrans-587
  prefs: []
  type: TYPE_NORMAL
- en: 'In the last chapter, [*Chapter 8*](B21008_08.xhtml#_idTextAnchor316), *Crowdstrike:
    Cybersecurity in the Era of Deepfakes*, we will venture into the fascinating world
    of CrowdStrike – a global leader in cybersecurity. Through the lens of Power BI
    visualizations, we will explore aggressive and conservative trade strategies,
    unveiling a remarkable symphony of technology, finance, and innovation. From the
    pulsating beats of cyber insurance to the melodious strains of quantum computing,
    our journey will resonate with investors, tech enthusiasts, and anyone intrigued
    by the future of cybersecurity.'
  id: totrans-588
  prefs: []
  type: TYPE_NORMAL
- en: 'In the next chapter, prepare to be captivated as we examine into the following
    topics:'
  id: totrans-589
  prefs: []
  type: TYPE_NORMAL
- en: '**CrowdStrike’s strengths and weaknesses**: A SCORE analysis revealing the
    company’s standing in the digital arena'
  id: totrans-590
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Innovative trading strategies**: Learn to leverage options and stocks in
    the cybersecurity sector, guided by Power BI visualizations'
  id: totrans-591
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**HackerGPT’s expertise**: Discover a highly intelligent model that monitors
    cybersecurity regulatory changes and breaches'
  id: totrans-592
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Deepfakes and AI’s power**: Unmask the truth behind deepfakes and how AI
    tools such as ChatGPT can protect digital integrity'
  id: totrans-593
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: '**Your passport to the AI future**: Embark on the AI learning journey, transforming
    trading, investing, and financial reporting'
  id: totrans-594
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
